{
  "success": true,
  "data": {
    "id": 97931543,
    "linkedin_source_id": "106033432",
    "name": "aiomics",
    "created_at": "2025-02-16",
    "last_updated": "2025-10-16",
    "websites_main": "https://aiomics.io",
    "websites_resolved": "https://www.aiomics.io/",
    "websites_main_original": "www.aiomics.io",
    "unique_website": true,
    "unique_domain": true,
    "expired_domain": false,
    "websites_linkedin": "https://www.linkedin.com/company/aiomics",
    "websites_linkedin_canonical": "https://de.linkedin.com/company/aiomics",
    "social_linkedin_urls": null,
    "websites_facebook": null,
    "social_facebook_urls": null,
    "websites_twitter": null,
    "social_twitter_urls": null,
    "social_x_urls": null,
    "social_instagram_urls": null,
    "social_youtube_urls": null,
    "social_github_urls": null,
    "social_reddit_urls": null,
    "social_discord_urls": null,
    "social_pinterest_urls": null,
    "social_tiktok_urls": null,
    "logo": "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",
    "enriched_b2b": 1,
    "ticker": null,
    "exchange": null,
    "description": "Across Europe, healthcare providers lose hours every day to fragmented documentation\u2014handwritten notes, scanned PDFs, dictations, disconnected IT systems. The result: burnout, missed revenue, and patients feeling like they\u2019re asked the same question three times.\n\nAiomics changes this. Our AI-driven co-pilot captures every clinical detail\u2014speech, handwriting, digital notes\u2014and validates it in real time with a human-in-the-loop process. Interactive checklists surface missing information before the patient leaves, and audit-ready records flow straight back into existing systems. Built for GDPR, MDR, and the EU AI Act from day one, Aiomics makes documentation complete, compliant, and instantly usable.\n\nWe don\u2019t replace EHRs\u2014we make them better. From admission and discharge reports to insurer forms, from therapist briefings to patient-friendly letters, Aiomics turns paperwork from a burden into an asset. For providers, that means fewer errors, faster reimbursements, and\u2014most importantly\u2014more time at the bedside.\n\nOur mission: to empower healthcare professionals by removing administrative burdens and elevating their decision-making with trusted AI guidance\u2014so they can reconnect with why they chose this vocation in the first place.\n\nWho we are:\nAiomics is co-founded by Dr. Sven Jungmann, a physician with frontline experience of administrative overload; Dr. Nikita Tarasov, a physicist and data scientist; and a lawyer [to be announced soon] who scaled one of Europe\u2019s largest digitally enabled hospitality companies. Together, we unite empathy, technical mastery, and regulatory expertise to build the trusted co-pilot for Europe\u2019s healthcare providers.",
    "enriched_summary": null,
    "metadata_title": "Aiomics: AI-Powered Medtech Compliance & Real-Time Device Insights | Aiomics",
    "metadata_description": "Automate support, simplify MDR/FDA compliance, and gain real-time device visibility\u2014without reclassification. Unlock AI-driven medtech innovation with aiomics.",
    "industry": "Technology, Information and Internet",
    "specialities": [
      "Customer Support",
      "Customer Care",
      "Medical Technology",
      "Artificial Intelligence",
      "Trend Reporting",
      "Data Analytics",
      "Customer Insights",
      "AI in Healthcare",
      "Workflow Automation",
      "Cyber Security",
      "ISO 27001",
      "ISO 42001",
      "Patient Engagement",
      "Remote Patient Monitoring",
      "GDPR Compliance",
      "Healthcare SaaS",
      "Telemedicine",
      "AI-driven Healthcare"
    ],
    "enriched_keywords": [
      "real-time device insights",
      "seamless support",
      "AI-powered medtech",
      "compliance",
      "compliance headaches"
    ],
    "enriched_category": "Medtech Compliance",
    "type": "Privately Held",
    "founded": "2025",
    "size_range": "1-10 employees",
    "size_employees_count": 4,
    "size_employees_count_inferred": 2,
    "followers": 1075,
    "location_hq_raw_address": "Berlin, Germany",
    "location_hq_country": "Germany",
    "location_hq_regions": [
      "Europe",
      "Western Europe",
      "EMEA",
      "European Union"
    ],
    "locations_full": [
      {
        "location_address": "Berlin, DE",
        "is_primary": true
      }
    ],
    "updates": [
      {
        "followers": 1075,
        "date": "1d",
        "description": "Data security in healthcare is, needless to say, non-negotiable. But how do you prove it?\u00a0We are glad to announce that our Trust Center via Vanta just went live. It allows you to see in real-time what we are in compliance with. \n\n\nhttps://trust.aiomics.io/",
        "reactions_count": 9,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "3d",
        "description": "Liebe Linkedin-Community,\n\nheute hab ich einen irre inspirierenden Podcast-Gast f\u00fcr euch. Warum? Weil sich jeder von uns gl\u00fccklich sch\u00e4tzen kann, wenn sein Startup so richtig durch die Decke geht. \n\nDr. Sven Jungmann ist Arzt, Unternehmer und Gr\u00fcnder von aiomics.\nH\u00f6rt gerne zu, wie er \u00fcber seine Mission im Gesundheitswesen spricht und was das genau mit KI zu tun hat.\n\nDanke lieber Sven f\u00fcr dieses Interview. Euch bei aiomics ganz viel Erfolg mit eurer Plattform und sch\u00f6n, dass wir uns nun auch beruflich \u00fcber den Weg laufen!",
        "reactions_count": 22,
        "comments_count": 2,
        "reshared_post_author": "bwiiw",
        "reshared_post_author_url": "https://de.linkedin.com/company/bwiiw",
        "reshared_post_author_headline": null,
        "reshared_post_description": "Diese Woche gibt es auch wieder eine ganz besondere Podcast-Folge auf die Ohren. \nIch spreche mit Dr. Sven Jungmann \u00fcber die Chancen von KI in Healthcare, \u00fcber die Notwendigkeit der Integration von Patientendaten und die Pre-Seed Runde seines Unternehmens aiomics.\n\nH\u00f6rt gerne rein unter:\nhttps://lnkd.in/dKfRjTvs\n\nSvens Mission ist es, Klinikpersonal ihre Zeit zur\u00fcckzugeben. Zeit f\u00fcr Arbeit an Patientin und Patient anstelle von Paperwork. \nEr entwickelt mit seinem Team den KI Copiloten f\u00fcr das Gesundheitswesen.\nIhr findet aiomics unter https://www.aiomics.io/\nund Dr. Sven Jungmann nat\u00fcrlich hier auf auf Linkedin.",
        "reshared_post_date": "3d",
        "reshared_post_followers": null
      },
      {
        "followers": 1075,
        "date": "1w",
        "description": "We are, of course, a healthcare company.\n\nBut ultimately, our mission is to strengthen resilience \u2014 in people, in systems, and in society.\n\nReducing the burden of messy patient data and documentation for healthcare providers is not just about efficiency or access. It\u2019s about ensuring surge capacity when it\u2019s most needed. It\u2019s about reducing waste. And most importantly, it\u2019s about giving back the energy and purpose that brought most healthcare professionals into patient care in the first place.\n\nAt a time when staff shortages are severe and many are leaving the field, this mission feels more urgent than ever. That\u2019s why we don\u2019t just stay in the digital-health bubble. We engage with the broader impact innovation community \u2014 to learn from other sectors and connect the missing links of a truly resilient society.\n\nHere\u2019s our founder, Dr. Sven Jungmann, sharing our work with impact founders and funders at Impact Week in Barcelona (Norrsken Barcelona) last week.",
        "reactions_count": 39,
        "comments_count": 2,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 807,
        "date": "2w",
        "description": "Vom Pilotprojekt zur Skalierung \u2013 wie wir #Innovation im Gesundheitswesen endlich gro\u00df machen.\nViele #KI-Projekte im Gesundheitswesen bleiben Pilotprojekte \u2013 die Wirkung verpufft.\nDoch: Skalierung ist der Schl\u00fcssel, wenn wir echte #Transformation wollen.\nIm Panel diskutieren: \nNicolas Weber (Healthcare Entrepreneur & Investor)\nDr. Sven Jungmann (aiomics) und\nDr. Tobias Daniel Gantner (HealthCare Futurists GmbH).\n\ud83d\udccd DGKIMED-Summit | 03.11.2025 | Potsdam\n\u2753Welche H\u00fcrde bremst aus Ihrer Sicht die Skalierung am meisten \u2013 Finanzierung, Akzeptanz oder Regulierung?\n\n \u27a1\ufe0f Jetzt anmelden: https://lnkd.in/dB6umXpy \nNicolas Weber Jens Schneider Thomas Moesta Prof. Dr. Stefan Heinemann Alexandra J\u00fcrgens Dr. Robert Jacob Siming Bayer Dr. Ilias Tsimpoulis",
        "reactions_count": 18,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "2w",
        "description": "The new Gestalt Podcast episode is out.\n\nWith our guest, Dr. Sven Jungmann \u2014 a medical doctor turned entrepreneur \u2014 we unveil cases and tools that work. Disqualify what does not.\n\nWe'd be curious to know what are you doing with AI at work? Drop your case, tools, agents \ud83e\udd19\n\n--\nThe podcast is available on Apple, Spotify, and YouTube. Find a link to your favorite platform in the sticky comment.\n\nIt's about psychology, philosophy, learnings and failures of 2 successful digital creators.",
        "reactions_count": 24,
        "comments_count": 7,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1075,
        "date": "2w",
        "description": "We\u2019re proud that our CEO, Dr. Sven Jungmann, contributed to human Magazin\u2019s special issue \u201chuman Forward \u2013 Smart Resilience: Defending Europe.\u201d [in German]\n\nThe interview touches on challenges that resonate far beyond hospitals:\nHealthcare\u2019s core bottleneck is staff shortages. According to World Health Organization, #Europe will be missing 4+ millions of professionals by 2030. This isn\u2019t just an economic issue\u2014it threatens care quality and access.\nDocumentation is a silent drain. Doctors and nurses spend hours every day on paperwork instead of patients. Reducing this burden is one of the fastest ways to strengthen resilience in healthcare.\n\nThe physician\u2013patient relationship is shifting. With tools like #ChatGPT, patients come better informed and more proactive. That creates both pressure and opportunity for clinicians\u2014opening the door for more dialogue on equal footing.\n\nWe truly value human Magazin\u2019s mission to explore resilience and democracy with a human-centred lens. Conversations like these remind us that technology alone isn\u2019t enough: it has to serve people, values, and society.\n\n\ud83d\udc49 The full publication is available here: https://lnkd.in/e84XJwxa \n\n#healthcare #resilience #AI #humanintheloop #digitalhealth",
        "reactions_count": 3,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1075,
        "date": "3w",
        "description": "Get an impression how our CEO thinks about innovation.",
        "reactions_count": 7,
        "comments_count": null,
        "reshared_post_author": "Nik Sumeiko",
        "reshared_post_author_url": "https://at.linkedin.com/in/niksumeiko",
        "reshared_post_author_headline": "React/Nextjs, TDD, Clean Architecture made simple",
        "reshared_post_description": "A new Gestalt Podcast episode will go out next week. Here's a trailer \ud83c\udf99\ufe0f\n\nWe will discuss:\n- Why learning fast beats years of experience\n- Where AI helps in healthcare, startups, and daily life\u00a0\u00a0\n- How clear communication makes AI useful (or useless)\u00a0 \n\nTogether with Marius Bauer, I run the Gestalt podcast \u2014 a space where we explore psychology, tech, and the human side of being a creator.\u00a0 \n\nThis time with our guest Dr. Sven Jungmann, a doctor and founder in digital health.\u00a0 \n\nStay tuned on your favorite platform.\u00a0\u00a0\nLet's grow with AI together \ud83d\ude4c \u2063\n\u2063",
        "reshared_post_date": "3w",
        "reshared_post_followers": null
      },
      {
        "followers": 1075,
        "date": "3w",
        "description": "\ud83d\ude91 Warum scheitern digitale Innovationen im Krankenhaus?\n\nOb KI-gest\u00fctzte Dokumentation, Telemonitoring oder Robotik \u2013 es fehlt nicht an Technologien im Gesundheitswesen. Aber warum bleiben so viele Innovationen im Pilotprojekt stecken und schaffen es nicht in die klinische Routine?\nDar\u00fcber hat unser Dr. Sven Jungmann mit Prof. Akira Poncette, An\u00e4sthesiologe, Medizininformatiker und Professor f\u00fcr Clinical Implementation Science an der Charit\u00e9 - Universit\u00e4tsmedizin Berlin, gesprochen.\n\nSie diskutieren u. a.:\n \ud83d\udd39 Warum Technologien oft nicht an der Idee, sondern am Kontext scheitern\n \ud83d\udd39 Welche Rolle Implementierungswissenschaft spielt und welche Frameworks Kliniken wirklich weiterhelfen\n \ud83d\udd39 Wie schon drei Workshops den Unterschied machen k\u00f6nnen\n \ud83d\udd39 Warum das lernende Krankenhaus die einzig realistische Vision f\u00fcr die Zukunft ist\n\nWir freuen uns auf eure Gedanken: Wie schafft ihr es, digitale Projekte nachhaltig in den Klinikalltag zu bringen?\n\n#DigitalHealth #Krankenhausmanagement #Innovation #Implementierungswissenschaft",
        "reactions_count": 10,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1075,
        "date": "3w",
        "description": "\ud83d\ude91 Warum scheitern so viele digitale Projekte in Krankenh\u00e4usern \u2013 obwohl die Technologie eigentlich funktioniert?\n\nIn unserer neuen Aiomics-Serie spricht unser Dr. Sven Jungmann mit Prof. Akira Poncette (Charit\u00e9 Berlin) \u00fcber ein Thema, das bisher viel zu wenig Beachtung findet: Implementierungswissenschaft.\n\n\ud83d\udc49 Was Sie in der Folge erfahren:\n- Warum es nicht reicht, \u201enur\u201c ein gutes Tool zu haben.\n- Welche Rolle Kontext, Strategie und Partizipation f\u00fcr den Erfolg spielen.\n- Wie Krankenhausleitungen mit klaren Frameworks (CFIR, ERIC) aus dem Trial & Error herauskommen.\n- Praktische Ans\u00e4tze: drei kurze Workshops, Champions im Team, hybride Studien.\n- Was ein \u201elernendes Krankenhaus\u201c ausmacht \u2013 und warum das die Zukunft ist.\n\n\ud83c\udfa5 Das Gespr\u00e4ch richtet sich an Krankenhausleitungen, \u00c4rztliche Direktor:innen, IT-Verantwortliche und alle, die Innovation wirklich in die Praxis bringen wollen.\n\n\u27a1\ufe0f https://lnkd.in/eZuk9T46\n\nFazit: Technologie allein reicht nicht. Wer wissen will, wie digitale Projekte wirklich erfolgreich werden, sollte dieses Interview nicht verpassen.",
        "reactions_count": 23,
        "comments_count": 2,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1056,
        "date": "18h",
        "description": "We are, of course, a healthcare company.\n\nBut ultimately, our mission is to strengthen resilience \u2014 in people, in systems, and in society.\n\nReducing the burden of messy patient data and documentation for healthcare providers is not just about efficiency or access. It\u2019s about ensuring surge capacity when it\u2019s most needed. It\u2019s about reducing waste. And most importantly, it\u2019s about giving back the energy and purpose that brought most healthcare professionals into patient care in the first place.\n\nAt a time when staff shortages are severe and many are leaving the field, this mission feels more urgent than ever. That\u2019s why we don\u2019t just stay in the digital-health bubble. We engage with the broader impact innovation community \u2014 to learn from other sectors and connect the missing links of a truly resilient society.\n\nHere\u2019s our founder, Dr. Sven Jungmann, sharing our work with impact founders and funders at Impact Week in Barcelona (Norrsken Barcelona) last week.",
        "reactions_count": 23,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 770,
        "date": "4d",
        "description": "Vom Pilotprojekt zur Skalierung \u2013 wie wir #Innovation im Gesundheitswesen endlich gro\u00df machen.\nViele #KI-Projekte im Gesundheitswesen bleiben Pilotprojekte \u2013 die Wirkung verpufft.\nDoch: Skalierung ist der Schl\u00fcssel, wenn wir echte #Transformation wollen.\nIm Panel diskutieren: \nNicolas Weber (Healthcare Entrepreneur & Investor)\nDr. Sven Jungmann (aiomics) und\nDr. Tobias Daniel Gantner (HealthCare Futurists GmbH).\n\ud83d\udccd DGKIMED-Summit | 03.11.2025 | Potsdam\n\u2753Welche H\u00fcrde bremst aus Ihrer Sicht die Skalierung am meisten \u2013 Finanzierung, Akzeptanz oder Regulierung?\n\n \u27a1\ufe0f Jetzt anmelden: https://lnkd.in/dB6umXpy \nNicolas Weber Jens Schneider Thomas Moesta Prof. Dr. Stefan Heinemann Alexandra J\u00fcrgens Dr. Robert Jacob Siming Bayer Dr. Ilias Tsimpoulis",
        "reactions_count": 13,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "1w",
        "description": "The new Gestalt Podcast episode is out.\n\nWith our guest, Dr. Sven Jungmann \u2014 a medical doctor turned entrepreneur \u2014 we unveil cases and tools that work. Disqualify what does not.\n\nWe'd be curious to know what are you doing with AI at work? Drop your case, tools, agents \ud83e\udd19\n\n--\nThe podcast is available on Apple, Spotify, and YouTube. Find a link to your favorite platform in the sticky comment.\n\nIt's about psychology, philosophy, learnings and failures of 2 successful digital creators.",
        "reactions_count": 22,
        "comments_count": 7,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1056,
        "date": "1w",
        "description": "We\u2019re proud that our CEO, Dr. Sven Jungmann, contributed to human Magazin\u2019s special issue \u201chuman Forward \u2013 Smart Resilience: Defending Europe.\u201d [in German]\n\nThe interview touches on challenges that resonate far beyond hospitals:\nHealthcare\u2019s core bottleneck is staff shortages. According to World Health Organization, #Europe will be missing 4+ millions of professionals by 2030. This isn\u2019t just an economic issue\u2014it threatens care quality and access.\nDocumentation is a silent drain. Doctors and nurses spend hours every day on paperwork instead of patients. Reducing this burden is one of the fastest ways to strengthen resilience in healthcare.\n\nThe physician\u2013patient relationship is shifting. With tools like #ChatGPT, patients come better informed and more proactive. That creates both pressure and opportunity for clinicians\u2014opening the door for more dialogue on equal footing.\n\nWe truly value human Magazin\u2019s mission to explore resilience and democracy with a human-centred lens. Conversations like these remind us that technology alone isn\u2019t enough: it has to serve people, values, and society.\n\n\ud83d\udc49 The full publication is available here: https://lnkd.in/e84XJwxa \n\n#healthcare #resilience #AI #humanintheloop #digitalhealth",
        "reactions_count": 3,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1056,
        "date": "2w",
        "description": "Get an impression how our CEO thinks about innovation.",
        "reactions_count": 7,
        "comments_count": null,
        "reshared_post_author": "Nik Sumeiko",
        "reshared_post_author_url": "https://at.linkedin.com/in/niksumeiko",
        "reshared_post_author_headline": "React/Nextjs, TDD, Clean Architecture made simple",
        "reshared_post_description": "A new Gestalt Podcast episode will go out next week. Here's a trailer \ud83c\udf99\ufe0f\n\nWe will discuss:\n- Why learning fast beats years of experience\n- Where AI helps in healthcare, startups, and daily life\u00a0\u00a0\n- How clear communication makes AI useful (or useless)\u00a0 \n\nTogether with Marius Bauer, I run the Gestalt podcast \u2014 a space where we explore psychology, tech, and the human side of being a creator.\u00a0 \n\nThis time with our guest Dr. Sven Jungmann, a doctor and founder in digital health.\u00a0 \n\nStay tuned on your favorite platform.\u00a0\u00a0\nLet's grow with AI together \ud83d\ude4c \u2063\n\u2063",
        "reshared_post_date": "2w",
        "reshared_post_followers": null
      },
      {
        "followers": 1056,
        "date": "2w",
        "description": "\ud83d\ude91 Warum scheitern digitale Innovationen im Krankenhaus?\n\nOb KI-gest\u00fctzte Dokumentation, Telemonitoring oder Robotik \u2013 es fehlt nicht an Technologien im Gesundheitswesen. Aber warum bleiben so viele Innovationen im Pilotprojekt stecken und schaffen es nicht in die klinische Routine?\nDar\u00fcber hat unser Dr. Sven Jungmann mit Prof. Akira Poncette, An\u00e4sthesiologe, Medizininformatiker und Professor f\u00fcr Clinical Implementation Science an der Charit\u00e9 - Universit\u00e4tsmedizin Berlin, gesprochen.\n\nSie diskutieren u. a.:\n \ud83d\udd39 Warum Technologien oft nicht an der Idee, sondern am Kontext scheitern\n \ud83d\udd39 Welche Rolle Implementierungswissenschaft spielt und welche Frameworks Kliniken wirklich weiterhelfen\n \ud83d\udd39 Wie schon drei Workshops den Unterschied machen k\u00f6nnen\n \ud83d\udd39 Warum das lernende Krankenhaus die einzig realistische Vision f\u00fcr die Zukunft ist\n\nWir freuen uns auf eure Gedanken: Wie schafft ihr es, digitale Projekte nachhaltig in den Klinikalltag zu bringen?\n\n#DigitalHealth #Krankenhausmanagement #Innovation #Implementierungswissenschaft",
        "reactions_count": 10,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1056,
        "date": "2w",
        "description": "\ud83d\ude91 Warum scheitern so viele digitale Projekte in Krankenh\u00e4usern \u2013 obwohl die Technologie eigentlich funktioniert?\n\nIn unserer neuen Aiomics-Serie spricht unser Dr. Sven Jungmann mit Prof. Akira Poncette (Charit\u00e9 Berlin) \u00fcber ein Thema, das bisher viel zu wenig Beachtung findet: Implementierungswissenschaft.\n\n\ud83d\udc49 Was Sie in der Folge erfahren:\n- Warum es nicht reicht, \u201enur\u201c ein gutes Tool zu haben.\n- Welche Rolle Kontext, Strategie und Partizipation f\u00fcr den Erfolg spielen.\n- Wie Krankenhausleitungen mit klaren Frameworks (CFIR, ERIC) aus dem Trial & Error herauskommen.\n- Praktische Ans\u00e4tze: drei kurze Workshops, Champions im Team, hybride Studien.\n- Was ein \u201elernendes Krankenhaus\u201c ausmacht \u2013 und warum das die Zukunft ist.\n\n\ud83c\udfa5 Das Gespr\u00e4ch richtet sich an Krankenhausleitungen, \u00c4rztliche Direktor:innen, IT-Verantwortliche und alle, die Innovation wirklich in die Praxis bringen wollen.\n\n\u27a1\ufe0f https://lnkd.in/eZuk9T46\n\nFazit: Technologie allein reicht nicht. Wer wissen will, wie digitale Projekte wirklich erfolgreich werden, sollte dieses Interview nicht verpassen.",
        "reactions_count": 21,
        "comments_count": 2,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 9021,
        "date": "2w",
        "description": "\"Berlin\u2019s Aiomics Raises \u20ac2M to Tackle Europe\u2019s Healthcare Documentation Burden.\"\n\nBerlin based HealthTech startup aiomics has raised \u20ac2 million in pre-seed funding to scale its AI-powered documentation platform across diverse care settings and prepare for expansion into new European markets.\n\nThe round was led by Vorwerk Ventures, with participation from Calm/Storm, Norrsken Evolve, rule30, and notable business angels such as Konstantin Othmer, Nicolas Weber, Andrea Kranzer, and Markus Wild. Investors see Aiomics as part of a larger shift in clinical software, where AI-driven solutions are unbundling traditional systems to deliver more flexible, context aware tools.\n\nFounded in 2025 by Dr. Sven Jungmann, Dr. Nikita Tarasov, and Kirill Schitomirski, Aiomics is on a mission to reduce administrative overhead for clinicians, nurses, and therapists. Its platform captures speech, handwriting, and documents in one validated workflow, checks for completeness and consistency, and feeds structured, audit secure data back into hospital systems.\n\nBy minimizing documentation errors, accelerating reimbursements, and freeing up time for patient care, Aiomics is tackling one of Europe\u2019s most persistent healthcare challenges: the administrative burden draining medical staff resources. With fresh funding, the company plans to extend its platform into hospitals, rehabilitation centers, and telemedicine providers while entering additional European markets.\n\nAs Europe grapples with workforce shortages and rising demand for care, Aiomics\u2019 promise is simple but powerful: let doctors treat patients, not paperwork.\n\n#HealthTech #DigitalHealth #AIinHealthcare #HealthcareInnovation #PreSeedFunding #Startups #ImpactTech #HealthcareTransformation #EuropeanTech #Aiomics #cxolanes",
        "reactions_count": 62,
        "comments_count": 2,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1056,
        "date": "2w",
        "description": "We're growing \u2014 please let us know if you know great software developers, application security engineers, product managers (need a medical background and German skills), and a budding entrepreneurial mind.",
        "reactions_count": 26,
        "comments_count": 2,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 280408,
        "date": "1d",
        "description": "F\u00fcrchtet euch nicht!\n\n\ud83d\udfe3 GR\u00dcNDERSZENE DAILY NEWSLETTER 05.09.2025 \ud83d\udfe3 \n\nAlle reden von GenAI \u2013 aber die\u00a0n\u00e4chste KI ist schon da.\u00a0Agentic AI denkt, plant und handelt selbst. Sie orchestriert Workflows, trifft Entscheidungen und erledigt Aufgaben, w\u00e4hrend wir noch \u00fcberlegen, was wir fragen sollen. Keine Theorie mehr, kein \u201evielleicht irgendwann\u201c \u2013 die Zukunft ist jetzt. Lets go!\n\nP.S.\u00a0Und nach Agentic AI kommt auch schon was... \u201eUnd davor haben wir alle Angst\u201c, sagte uns WeAreDevelopers-Gr\u00fcnder Sead Ahmetovic\n\n\ud83d\udc49 Gr\u00fcnder & VCs lesen t\u00e4glich Gr\u00fcnderszene Daily. \nHier kostenlos Teil der Gr\u00fcnderszene werden: https://lnkd.in/dY3JHneW \n\nAu\u00dferdem im Newsletter:\n\n\ud83d\udfe3 Lea-Sophie Cramer\u00a0is back\n\ud83d\udfe3 Finanzierung incoming:\u00a0Mistral AI-Wert steigt auf 14 Milliarden Dollar\n\ud83d\udfe3 aiomics macht \u00c4rzte happy:\u00a0KI sortiert\u00a0das Patientenpapierchaos\n\ud83d\udfe3 MRM Health pimpt dein Mikrobiom:\u00a055 Mio. f\u00fcr neue Therapien gegen  Entz\u00fcndungen & Co.\n\ud83d\udfe3 \u00d6sterreich stoppt Geld-Abfluss:\u00a0neuer Startup-Dachfonds gegen VC-Flaute.\nViel Spa\u00df beim Lesen!\n\nEure Gr\u00fcnderszene-Redaktion \u2764\ufe0f",
        "reactions_count": 2,
        "comments_count": 2,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 1775,
        "date": "1d",
        "description": "\ud83c\udde9\ud83c\uddea Berlin-based\u00a0aiomics, a HealthTech company tackling Europe\u2019s medical documentation burden, has secured\u00a0\u20ac2 million in a pre-Seed round\u00a0led by Vorwerk Ventures, with participation from\u00a0Calm/Storm, Norrsken Evolve, rule30\u00a0and notable business angels including\u00a0Konstantin Othmer, Nicolas Weber, Andrea Kranzer and Markus Wild.\n\nFounded in 2025 by Dr. Sven Jungmann, Dr Nikita Tarasov and Kirill Schitomirski, Aiomics develops an\u00a0AI-powered documentation platform\u00a0designed to ease the workload of doctors, nurses, and therapists. \n\nBy capturing speech, handwriting, and documents in one validated workflow and returning structured, coded, and audit-secure data, Aiomics reduces errors, accelerates reimbursements, and frees clinicians to spend more time on patient care.\n\nWith this fresh capital, the company will\u00a0expand its platform, scale across acute hospitals, rehabilitation centers and telemedicine providers, and prepare entry into new European markets, pushing forward its mission of\u00a0relieving healthcare systems from administrative overload\u00a0and empowering medical staff.",
        "reactions_count": 45,
        "comments_count": 3,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 63346,
        "date": "2d",
        "description": "The energy in Stockholm House is still high as the 2025 Norrsken Evolve sprint continues.\n\nNext up under the spotlight from this year\u2019s 2025 Norrsken Evolve Portfolio is aiomics, founded by Dr. Sven Jungmann, Dr Nikita Tarasov and Kirill Schitomirski.\n\nAnd congratulations on already closing your fabulous \u20ac2M pre\u2011seed round, with backing from\u00a0Vorwerk Ventures and Calm/Storm. \n\nWelcome to Stockholm, aiomics!\n\nnote: it seems like an error made it to the 4th slide. The company is aiomics, a health tech based in Germany, with Sven Jungmann featured. Not TetraxAI as displayed. Our apologies for the confusion it may have caused!",
        "reactions_count": 44,
        "comments_count": 3,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 127339,
        "date": "2d",
        "description": "German HealthTech company aiomics has successfully closed a \u20ac2 million pre-Seed financing round to expand its platform, scale to diverse care settings and prepare for entry into additional European markets \ud83c\udde9\ud83c\uddea \ud83c\udf1f\n\nThe round was led by Vorwerk Ventures with participation from Calm/Storm, Norrsken Evolve, and rule30. Several renowned business angels also joined the round, including Konstantin Othmer, Nicolas Weber, and Markus Wild.\n\n\u201cThe clinical software landscape is undergoing a fundamental transformation: artificial intelligence is driving the unbundling of existing systems. Unlike traditional software, AI can adapt much more granularly to the individual realities of different hospitals, departments, and specialties. This enables solutions like Aiomics to integrate faster and more seamlessly \u2013 with enormous potential for European healthcare,\u201d said Sascha Guenther, Partner at Vorwerk Ventures.\n\nhttps://lnkd.in/d82Afpvr",
        "reactions_count": 33,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 2946,
        "date": "2d",
        "description": "Berlin-based aiomics has raised \u20ac2M in pre-seed funding at a \u20ac10M valuation to reduce the burden of medical documentation across European healthcare.\n\nLed by Dr. Sven Jungmann, Dr. Nikita Tarasov, and Kirill Schitomirski, Aiomics integrates speech, handwriting, and documents into one validated workflow with human-in-the-loop checks. Hospitals gain structured, audit-secure data that improves coding accuracy, accelerates reimbursements, and gives clinicians more time with patients.\n\nThe round was led by Vorwerk Ventures, with Calm/Storm, Norrsken Evolve, rule30, and notable angels like Konstantin Othmer, Nicolas Weber, Andrea Kranzer, and Markus Wild. Aiomics plans to scale into hospitals, rehab centers, and telemedicine providers, starting with Germany and Sweden.\n\nRead full article: https://lnkd.in/gU-ybwuU",
        "reactions_count": 109,
        "comments_count": 8,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 56089,
        "date": "2d",
        "description": "aiomics, a Berlin-based healthtech company, has closed a \u20ac2 million pre-seed funding round at a \u20ac10 million post-money valuation. \n\nThe round was led by Vorwerk Ventures, with participation from Calm/Storm, Norrsken Evolve and rule30. \n\nMore details: https://lnkd.in/g2ayTxqU\n\nDr. Sven Jungmann Nikita Tarasov Kirill Schitomirski \n\n#ai #artificialintelligence #innovation #eutech #investment #funding #germany #healthcare #documentation #startups #womenintech #femalefounders",
        "reactions_count": 19,
        "comments_count": 3,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 626,
        "date": "2d",
        "description": "It's official now\u2014we\u2019ve raised a \u20ac2M pre\u2011seed to build a healthcare co\u2011pilot that gives healthcare workers the time, guidance, and insight to return to their calling. Our goal is not just to cut admin\u2014it\u2019s to turn fragmented inputs into reliable, coded, audit\u2011ready data that supports better decisions across care and operations. We're not another scribe company, we're orchestrating data along the care journey beyond speech-to-text.\n\nWe\u2019re now shipping a hospital\u2011grade data\u2011quality layer that captures documents (printed and digital), handwriting, and speech in one validated workflow (with human\u2011in\u2011the\u2011loop), flags gaps in real time, and feeds structured outputs back into existing systems and deploys AI assistants to take away most of the annoying documentation work that none of our users ever wanted to do in the first place.\n\nWe\u2019re proud to be backed by institutional investors who truly understand healthcare and impact: Vorwerk Ventures, Calm/Storm, Norrsken Evolve, and rule30. \n\nAfter years as an operator, funder, and advisor in this field, our founder and CEO Dr. Sven Jungmann learned to value professional investors who actually understand healthcare and impact. There are too many trend surfers trying to import playbooks from unrelated industries. The teams behind our VCs are different\u2014thoughtful, domain\u2011literate, and constructive. We can only recommend them to other health\u2011tech founders.\n\nDeep thanks also to our angels: Konstantin Othmer, Nicolas Weber, Markus Wild, Christian Macht, Eddy Moosavi Pour, Steffen P Walz, and Bertram Duerr (and two more who prefer not to be named). You came in when things were still uncertain. This means the world and makes a huge difference.\n\nWe have big plans for Europe\u2014more on what we\u2019re rolling out next very soon.\n Handelsblatt covered the story today; link in the first comment.\n\n#healthtech #AI #hospitals #medtech #compliance #Europe #startups #Aiomics",
        "reactions_count": 58,
        "comments_count": 20,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 626,
        "date": "4d",
        "description": "We are glad to announce that our new webpage is online. Looking forward to your feedback.\u00a0www.aiomics.io \ud83d\ude0a",
        "reactions_count": 26,
        "comments_count": 3,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 626,
        "date": "4d",
        "description": "We\u2019re hiring: Senior Application Security Engineer (Next.js & Cloud\u2011Native HealthTech)\n\nAt aiomics, we build the cloud\u2011and\u2011AI layer hospitals actually adopt\u2014secure, private, and intuitive so clinicians can focus on care. Security isn\u2019t a gate here; it\u2019s a core product capability and a durable edge we plan to keep.\n\nMission\nLead Aiomics to stay ahead on application security. Build the practices, guardrails, and culture so that trust is the default\u2014before patient data ever touches our systems.\n\nWhat you\u2019ll do (high\u2011leverage work)\n- Establish the application security function end\u2011to\u2011end for a Next.js platform (Server Actions, API routes).\n- Threat\u2011model critical user journeys (patient data access, practitioner authentication) and turn insights into a living roadmap.\n- Integrate SAST/SCA into CI/CD for fast, useful feedback; tune for signal over noise.\n- Partner with our cloud team to harden AWS/Vercel/Clerk and reduce high\u2011severity findings.\n- Publish clear, pragmatic secure\u2011coding guidelines and lightweight docs the team will actually use.\n- Run a respectful, well\u2011structured responsible disclosure program and be a great counterpart to researchers.\n\nWhat we expect\n- You\u2019ve found and fixed critical web vulns (OWASP Top 10) in modern JS apps\u2014ideally Next.js.\n- You understand authN/authZ in practice (JWTs, sessions, middleware) and how to keep them robust.\n- You\u2019re comfortable with AWS security tooling (Security Hub, GuardDuty, IAM Access Analyzer).\n- You communicate risk clearly, make trade\u2011offs explicit, and keep momentum.\n\nHow we work\n- Tight iteration loops, whole\u2011journey reviews, and shipping small slices to validate assumptions early. We build to a medical\u2011device standard of quality (traceability, risk thinking, HIPAA/GDPR) from day one.\nSetup\n- Full\u2011time employment in Germany (required), we do not sponsor working permits.\n- Berlin or remote (EU time zones); occasional site visits optional.\n\nIf this is your kind of challenge, let\u2019s talk (contact CEO Dr. Sven Jungmann).",
        "reactions_count": 19,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 626,
        "date": "4d",
        "description": "We\u2019re thrilled to welcome\u00a0Kirill Schitomirski\u00a0as our founding COO & CLO at aiomics. \n\nKirill brings more than a decade of legal practice and first-hand scaling experience from\u00a0Numa group, where he helped grow from 1 hotel in #Berlin to more than 200 properties and over 10,000 units across 16 countries. \n\nAt aiomics, he\u2019ll focus on creating smooth operations and embedding compliance into everything we do. Healthcare often looks to aviation and gastronomy for lessons in safety and quality. We believe it can also learn from hospitality\u2014where operational excellence and customer experience go hand in hand.\n\nWelcome on board, Kirill! Glad to have you on board!",
        "reactions_count": 32,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 62910,
        "date": "4d",
        "description": "Norrsken Accelerator \u2192 Norrsken Evolve!\n\nEurope stands at a defining moment. In the face of unprecedented risks, our economies, industries, and ways of living, must evolve.\n\nToday we are proud to announce the close of Norrsken Evolve, a new \u20ac57m fund to back the founders building Europe\u2019s future, and an evolution of Norrsken Accelerator. \n\nSpearheaded by partners Rebecka L\u00f6thman Ryd\u00e5, Johan Attby and Alex Bakir, Norrsken Evolve invests in European founders and visionaries who will redefine how we generate energy, rebuild manufacturing, move goods, construct buildings, produce food & materials, treat our sick, secure our information and safeguard our societies from climate disruption. \n\n* \u20ac250k up-front investment\n* World-class in-person sprint\n* Top-tier advisory network\n\nThe oversubscribed close of the \u20ac57m Evolve fund was made possible with the support of institutional investors Saminvest AB, the European Investment Fund (EIF), and SmartCap Green Fund, funded by the European Union NextGenerationEU; as well as leading tech-founders and family offices.\n\nLearn more via link in comments.",
        "reactions_count": 256,
        "comments_count": 13,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "4d",
        "description": "I'm proud to announce that aiomics\u00a0is now backed by Norrsken Evolve, a pre-seed fund that invests in entrepreneurs building Europe's sustainable and resilient future. As part of this we've travelled to Sweden for a sprint, happening at the beautiful Norrsken House in my beloved Stockholm. \n\nIt takes a village to build a company. Thanks for the warm welcome Alex Bakir, Rebecka L\u00f6thman Ryd\u00e5, Johan Attby, Inez Atmer, Ebba Forsberg, Sjoerd Stevens & Edvin Eriksson! You have done a brilliant job at bringing a fantastic group of entrepreneurs together and to create the psychological safety and environment for us to learn and grow together as we are building our ventures.",
        "reactions_count": 275,
        "comments_count": 61,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "1w",
        "description": "\ud83d\udea8 We\u2019re hiring a UX/UI Designer @ Aiomics\n\n\ud83d\udccd Remote-first (Germany/EU) | \ud83d\udcbc Work permit for Germany required (German tax residency necessary) | \ud83d\udde3 Fluent German & English, ideally one more European language\n\nIf you could design something that gave doctors hours back every day \u2014 would you?\n\nEvery day in Europe, highly skilled clinicians spend almost as much time typing as treating. Nurses fill in the same information twice. Patients are asked the same question three times. Critical details get buried in PDFs. Meanwhile, staff shortages are at crisis levels, and burnout is driving talent out of healthcare.\n\nWe\u2019re here to change that.\n\nAt Aiomics, we capture and structure every important detail \u2014 from speech, handwriting, scans, or digital forms \u2014 so it\u2019s validated, coded, and ready to use in real time. We then deploy customisable AI assistants to take care of most soul draining tasks done manually by healthcare workers today. That means more time for care, fewer errors, faster reimbursements, and a safer, more human-centered healthcare system.\n\nYou\u2019d join a highly capable, low-ego team:\n\ud83e\ude7a A doctor with 10+ years in digital health and frontline clinical work\n\ud83e\uddee A physicist/data scientist with deep AI experience\n\u2696\ufe0f A lawyer who scaled a major tech company across Europe\n\ud83d\ude80 A product manager who worked for some of the best known health tech companies\n\ud83d\udcbb A top-notch software team with serious healthcare domain expertise\n\nWe\u2019re backed by leading healthcare & impact investors and work with some of Europe\u2019s most respected hospitals and research partners.\n\nWe\u2019re looking for someone who can:\n\u2013 Turn deep, multilingual UX research into designs that work in real clinics with real constraints\n\u2013 Move seamlessly between qualitative insights and quantitative validation \u2014 designing experiments, not just interfaces\n\u2013 Anticipate the regulatory and reimbursement realities that shape healthcare products\n\u2013 Craft AI-first, multimodal interactions (voice, handwriting, text, sensors) that feel natural and safe for users\n\u2013 Help us deliver on our early product promises fast, without compromising quality or trust\n\nIn your first 6\u201312 months, you might:\n\u2013 Create the machine\u2013human interaction blueprint that will define how our AI platform feels for years to come\n\u2013 Work directly with clinicians, nurses, therapists, and patients to design workflows that instantly save time and reduce burnout\n\u2013 Shape prototypes that make investors lean in \u2014 and make frontline staff say \u201cFinally, someone truly understands me\u201d\n\u2013 Prove that great design can thrive even under the strictest compliance rules\n\nThis isn\u2019t for everyone. Healthcare is complex, slow to change, and deeply regulated. But if you thrive where stakes are high, details matter, and the impact is real \u2014 you\u2019ll probably do the most meaningful work of your career here.\n\nLet\u2019s fix the way healthcare works, one interaction at a time.\n\n#hiring #ux #ui #designforimpact #digitalhealth #AI #multimodal #healthtech #aiomics #startupjobs",
        "reactions_count": 51,
        "comments_count": 7,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 385,
        "date": "2w",
        "description": "This one is in German: we are excited to have our CEO speak about simple and pragmatic ways of improving one's life for people living with obesity, end of next month.",
        "reactions_count": 4,
        "comments_count": null,
        "reshared_post_author": "Christel Moll",
        "reshared_post_author_url": "https://de.linkedin.com/in/christel-moll-20082ba2",
        "reshared_post_author_headline": "Vorsitzende beim Adipositas Verband Deutschland e.V. | SHG Betreuung, Seminare",
        "reshared_post_description": "\ud83c\udfa4 Vortrag beim Adipositastag NRW \u2013 20.09.2025\nK\u00fcnstliche Intelligenz (KI) \u2013 Chancen f\u00fcr Menschen mit Adipositas\n\nWas kann KI f\u00fcr Betroffene leisten?\nMehr als du denkst!\n\n\ud83d\udc68\u2695\ufe0f Dr. Sven Kaufmann zeigt in einfachen Worten:\n\u2705 Wie KI im Alltag unterst\u00fctzen kann\n\u2705 Welche Tools heute schon helfen\n\u2705 Warum das auch bei chronischen Erkrankungen wie Adipositas sinnvoll ist\n\n\ud83d\udcf1 Ohne Fachsprache \u2013 mit echten Beispielen!\n\ud83d\udca1 F\u00fcr Betroffene, Angeh\u00f6rige & Interessierte\n\n\ud83d\udccd Sei dabei beim Adipositastag NRW!\n\ud83d\uddd3 20.09.2025 | \ud83d\udccc Infos im Programm\n\n#AdipositastagNRW #K\u00fcnstlicheIntelligenz #AdipositasVerstehen #Patientenpower #DigitalHealth #ChronischeErkrankungen #Gesundheitskompetenz #1von19Millionen",
        "reshared_post_date": "2w",
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "1mo",
        "description": "\ud835\udc03\ud835\udc22\ud835\udc1e \ud835\udc19\ud835\udc2e\ud835\udc24\ud835\udc2e\ud835\udc27\ud835\udc1f\ud835\udc2d \ud835\udc22\ud835\udc2c\ud835\udc2d \ud835\udc20\ud835\udc1e\ud835\udc27\ud835\udc1a\ud835\udc2e \ud835\udc23\ud835\udc1e\ud835\udc2d\ud835\udc33\ud835\udc2d.\n\nDer #SummerSummit2025 war mein pers\u00f6nliches Highlight: \u00dcber 100 Patient:innenvertreter:innen bei Roche, vereint durch ein Ziel #NothingForPatientsWithoutPatients.\n\nUnter dem Motto \u201eMit deiner Stimme Zukunft gestalten\u201c sprachen wir offen \u00fcber fr\u00fche Patient:innenbeteiligung in Studien und mein Herzensthema: KI im Shared Decision Making.\n\nBesonders bewegend: Dr. Alexandra Widmer berichtete, wie eine Patientin sie fragte: \u201eMeine KI hat mir ein Medikament empfohlen - verschreiben Sie es mir?\u201c Ein Moment, der zeigt: Der Wandel ist l\u00e4ngst da.\n\nGemeinsam mit Inga Bergen, Dr. Sven Jungmann und Nele von Horsten sprachen wir \u00fcber das Whitepaper \u201eMit KI zur gemeinsamen Entscheidungsfindung in der Medizin\u201c - es b\u00fcndelt konkrete KI-Anwendungsbeispiele, Prompts und Perspektiven aus Medizin, Tech, Ethik und Recht. Im Zentrum steht die Frage: Wie schaffen wir eine verantwortungsvolle, zug\u00e4ngliche Nutzung von KI im Gesundheitswesen?\n\nFazit: \u201eEs ist ein Kunstfehler, heute keine KI einzusetzen.\u201c Oder wie Dario Madani sagte: \u201eKI geht in den Dialog. Sie macht Wissen zug\u00e4nglich.\u201c \n\n\ud83d\udc99Danke an Sarah Kuld & das gesamte Team f\u00fcr zwei Tage voller Haltung, Austausch und echter Begegnung - und an Jule Koger und Lukas Gro\u00df f\u00fcr die fantastische Zusammenarbeit!\n\n#KI4patients #SummerSummit",
        "reactions_count": 120,
        "comments_count": 10,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "2w",
        "description": "\ud83d\udea8 We\u2019re hiring a Full Stack Developer (frontend-leaning) @ aiomics\n\ud83d\udccd Remote-first (Germany/EU) | \ud83d\udcbc Work permit for Germany required\n\nHelp us build the AI infrastructure Europe\u2019s healthcare system urgently needs.\n\nAt aiomics, we\u2019re turning the tide on staff shortages and documentation overload by co-developing with clinicians, building AI tools that actually save time \u2014 not create more work. Our platform transforms messy medical data into structured, actionable documentation, improving care and freeing up capacity.\n\nYou\u2019d join a highly capable, low-ego team:\n\ud83e\udde0 A doctor with 10+ years in digital health (me)\n\ud83d\udcca A physicist/data scientist with deep AI experience\n\u2696\ufe0f A lawyer who scaled a major tech company\n\ud83d\udcbb A top-notch software team with serious healthcare domain expertise\n\nWe\u2019re backed by well-connected investors and preparing for large-scale implementations with leading hospitals.\n\nYou should bring:\n\u2013 Solid full stack experience with strong frontend capabilities\n\u2013 Familiarity with cloud infra (AWS preferred)\n\u2013 Curiosity, pragmatism, and high code quality standards\n\u2013 Comfort working in fast-moving, cross-functional teams\n\u2013 Prior health tech experience is a bonus, not a must\n\nThis is not a feature factory. This is AI done right, in service of real people. If that excites you, let\u2019s talk.\n\n\ud83d\udce9 DM me\n\n#hiring #fullstackdeveloper #frontend #AI #digitalhealth #aiomics #impactdriven #healthtech #startupjobs \ud83d\ude4b\u2642\ufe0f",
        "reactions_count": 49,
        "comments_count": 3,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "2w",
        "description": "aiomics w\u00e4chst \u2014 wer kann Talente empfehlen? Wir suchen Head of Product, UX/UI Designer, Clinical Manager, ML Engineer (AWS und/oder NLP Fokus). Vorzugsweise Standort Berlin, aber grunds\u00e4tzlich flexibel. Muss flie\u00dfend Deutsch sprechen. Klinik oder medizinische Erfahrung von gro\u00dfem Vorteil.\u00a0Wir starten mit guter Finanzierung und mehreren gr\u00f6\u00dferen Klinikpartnern, wie auch innovativen digitalen Gesundheitsanbietern.\u00a0Es gibt jede Menge zu tun, und wir haben eine wirklich spannende Wachstumskurve vor uns.\u00a0Das Team besteht ausnahmslos aus sehr seniorigen Experten mit ganz unterschiedlichen Hintergr\u00fcnden. Von Medizin \u00fcber Datenwissenschaften, Rechtswissenschaften und Co.",
        "reactions_count": 197,
        "comments_count": 21,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "3w",
        "description": "I've been giving a lot of talks to people working at the front lines of healthcare, and I'm clearly seeing a massive change in their perception of digitalization and artificial intelligence. \n\nEven in the most recent months or perhaps over the past year, it has become very clear to me that healthcare providers understand how fundamentally different the current AI era is from previous software, and there is a huge willingness to adopt new technologies, experiment, test, and contribute to their refinement \n\nHere is another really well-written article in German about the shared decision making white paper that I recently co-authored with different experts and representatives from Roche's Independent Patient Council.\n\nhttps://lnkd.in/evvD5A5p",
        "reactions_count": 111,
        "comments_count": 5,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 385,
        "date": "1mo",
        "description": "Artificial intelligence is fundamentally changing how patients and clinicians work together to solve health problems in a much more personalized way than what we used to see even just a few years ago. This was a great topic our CEO Dr. Sven Jungmann discussed with a group of patient experts recently in Grenzach-Wyhlen , the beautiful German headquarter of Roche. \n\nMore on this (in German for now, English coming soon) here: https://lnkd.in/eEw_YhDK",
        "reactions_count": 8,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 48436,
        "date": "1mo",
        "description": "Es ist wieder Zeit f\u00fcr neue Startups! Hier einige ganz junge Startups, die jeder kennen sollte. Heute stellen wir diese Jungunternehmen vor: aiomics, ArInLaS, bryo, Omnisent und ChangePath.\n\nhttps://lnkd.in/dE35RT29",
        "reactions_count": 3,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "1mo",
        "description": "\ud83c\udfe5 ML Engineer Opportunity: Build AI Infrastructure for European Healthcare \ud83c\udfe5\n\nWe're looking for an ML Engineer based in Germany to join our international team at aiomics. If you know someone great\u2014or if this sounds like you\u2014please reach out directly. \ud83d\ude4b\u2642\ufe0f \n\nWhat we're building: We're currently implementing our AI platform across 7 hospital facilities with advanced medical services. Our product is designed to save medical teams hours daily on documentation, using that time for meaningful patient care instead while having much better information on their patients. Our early hospital partners alone could reach 5M patients annually\u2014and we are only getting started. There have several more implementations in preparation right now.\n\nWhat we're working on: \n\u2022 Building ML systems that process unstructured medical data in various languages\u2014from handwritten notes to discharge letters to lab reports \n\u2022 Developing intelligent document extraction and structuring with ICD-10/SNOMED CT coding \n\u2022 Creating AI assistants that help draft all sorts of medical documentation, patient education material, and insurance and compliance forms \n\u2022 Designing for real-world healthcare: multilingual processing (24+ languages), GDPR/MDR compliance built in \n\u2022 Working on challenging NLP problems specific to European medical language patterns\n\nYou'll work directly with our CTO Nikita Tarasov on core infrastructure decisions and implement the latest ML technologies in a compliant manner. No competing projects\u2014just one product, built right.\n\nOur team: 5 core members from different countries, speaking 9 languages collectively. I'm a doctor-turned-founder, bringing healthcare expertise to technical decisions. We reason from first principles, move fast, remove roadblocks efficiently, and build solid foundations\u2014no shortcuts on quality.\n\nRequirements: \n\u2022 Work authorization in Germany \n\u2022 Drive to transform healthcare through technology\n\u2022 German language skills valuable (other European languages also great) \n\nWe prefer warm introductions\u2014no recruiters please. Join us in giving healthcare professionals their time back and enabling them to do what made them choose this profession in the first place: being there for their patients.\n\n#MachineLearning #HealthTech #MLJobs #GermanyJobs #AIEngineering",
        "reactions_count": 79,
        "comments_count": 8,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 310,
        "date": "20h",
        "description": "This one is in German: we are excited to have our CEO speak about simple and pragmatic ways of improving one's life for people living with obesity, end of next month.",
        "reactions_count": 1,
        "comments_count": null,
        "reshared_post_author": "Christel Moll",
        "reshared_post_author_url": "https://de.linkedin.com/in/christel-moll-20082ba2",
        "reshared_post_author_headline": "Vorsitzende beim Adipositas Verband Deutschland e.V. | SHG Betreuung, Seminare",
        "reshared_post_description": "\ud83c\udfa4 Vortrag beim Adipositastag NRW \u2013 20.09.2025\nK\u00fcnstliche Intelligenz (KI) \u2013 Chancen f\u00fcr Menschen mit Adipositas\n\nWas kann KI f\u00fcr Betroffene leisten?\nMehr als du denkst!\n\n\ud83d\udc68\u2695\ufe0f Dr. Sven Kaufmann zeigt in einfachen Worten:\n\u2705 Wie KI im Alltag unterst\u00fctzen kann\n\u2705 Welche Tools heute schon helfen\n\u2705 Warum das auch bei chronischen Erkrankungen wie Adipositas sinnvoll ist\n\n\ud83d\udcf1 Ohne Fachsprache \u2013 mit echten Beispielen!\n\ud83d\udca1 F\u00fcr Betroffene, Angeh\u00f6rige & Interessierte\n\n\ud83d\udccd Sei dabei beim Adipositastag NRW!\n\ud83d\uddd3 20.09.2025 | \ud83d\udccc Infos im Programm\n\n#AdipositastagNRW #K\u00fcnstlicheIntelligenz #AdipositasVerstehen #Patientenpower #DigitalHealth #ChronischeErkrankungen #Gesundheitskompetenz #1von19Millionen",
        "reshared_post_date": "1d",
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "3w",
        "description": "\ud835\udc03\ud835\udc22\ud835\udc1e \ud835\udc19\ud835\udc2e\ud835\udc24\ud835\udc2e\ud835\udc27\ud835\udc1f\ud835\udc2d \ud835\udc22\ud835\udc2c\ud835\udc2d \ud835\udc20\ud835\udc1e\ud835\udc27\ud835\udc1a\ud835\udc2e \ud835\udc23\ud835\udc1e\ud835\udc2d\ud835\udc33\ud835\udc2d.\n\nDer #SummerSummit2025 war mein pers\u00f6nliches Highlight: \u00dcber 100 Patient:innenvertreter:innen bei Roche, vereint durch ein Ziel #NothingForPatientsWithoutPatients.\n\nUnter dem Motto \u201eMit deiner Stimme Zukunft gestalten\u201c sprachen wir offen \u00fcber fr\u00fche Patient:innenbeteiligung in Studien und mein Herzensthema: KI im Shared Decision Making.\n\nBesonders bewegend: Dr. Alexandra Widmer berichtete, wie eine Patientin sie fragte: \u201eMeine KI hat mir ein Medikament empfohlen - verschreiben Sie es mir?\u201c Ein Moment, der zeigt: Der Wandel ist l\u00e4ngst da.\n\nGemeinsam mit Inga Bergen, Dr. Sven Jungmann und Nele von Horsten sprachen wir \u00fcber das Whitepaper \u201eMit KI zur gemeinsamen Entscheidungsfindung in der Medizin\u201c - es b\u00fcndelt konkrete KI-Anwendungsbeispiele, Prompts und Perspektiven aus Medizin, Tech, Ethik und Recht. Im Zentrum steht die Frage: Wie schaffen wir eine verantwortungsvolle, zug\u00e4ngliche Nutzung von KI im Gesundheitswesen?\n\nFazit: \u201eEs ist ein Kunstfehler, heute keine KI einzusetzen.\u201c Oder wie Dario Madani sagte: \u201eKI geht in den Dialog. Sie macht Wissen zug\u00e4nglich.\u201c \n\n\ud83d\udc99Danke an Sarah Kuld & das gesamte Team f\u00fcr zwei Tage voller Haltung, Austausch und echter Begegnung - und an Jule Koger und Lukas Gro\u00df f\u00fcr die fantastische Zusammenarbeit!\n\n#KI4patients #SummerSummit",
        "reactions_count": 119,
        "comments_count": 10,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "1d",
        "description": "\ud83d\udea8 We\u2019re hiring a Full Stack Developer (frontend-leaning) @ aiomics\n\ud83d\udccd Remote-first (Germany/EU) | \ud83d\udcbc Work permit for Germany required\n\nHelp us build the AI infrastructure Europe\u2019s healthcare system urgently needs.\n\nAt aiomics, we\u2019re turning the tide on staff shortages and documentation overload by co-developing with clinicians, building AI tools that actually save time \u2014 not create more work. Our platform transforms messy medical data into structured, actionable documentation, improving care and freeing up capacity.\n\nYou\u2019d join a highly capable, low-ego team:\n\ud83e\udde0 A doctor with 10+ years in digital health (me)\n\ud83d\udcca A physicist/data scientist with deep AI experience\n\u2696\ufe0f A lawyer who scaled a major tech company\n\ud83d\udcbb A top-notch software team with serious healthcare domain expertise\n\nWe\u2019re backed by well-connected investors and preparing for large-scale implementations with leading hospitals.\n\nYou should bring:\n\u2013 Solid full stack experience with strong frontend capabilities\n\u2013 Familiarity with cloud infra (AWS preferred)\n\u2013 Curiosity, pragmatism, and high code quality standards\n\u2013 Comfort working in fast-moving, cross-functional teams\n\u2013 Prior health tech experience is a bonus, not a must\n\nThis is not a feature factory. This is AI done right, in service of real people. If that excites you, let\u2019s talk.\n\n\ud83d\udce9 DM me\n\n#hiring #fullstackdeveloper #frontend #AI #digitalhealth #aiomics #impactdriven #healthtech #startupjobs \ud83d\ude4b\u2642\ufe0f",
        "reactions_count": 37,
        "comments_count": 3,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "6d",
        "description": "aiomics w\u00e4chst \u2014 wer kann Talente empfehlen? Wir suchen Head of Product, UX/UI Designer, Clinical Manager, ML Engineer (AWS und/oder NLP Fokus). Vorzugsweise Standort Berlin, aber grunds\u00e4tzlich flexibel. Muss flie\u00dfend Deutsch sprechen. Klinik oder medizinische Erfahrung von gro\u00dfem Vorteil.\u00a0Wir starten mit guter Finanzierung und mehreren gr\u00f6\u00dferen Klinikpartnern, wie auch innovativen digitalen Gesundheitsanbietern.\u00a0Es gibt jede Menge zu tun, und wir haben eine wirklich spannende Wachstumskurve vor uns.\u00a0Das Team besteht ausnahmslos aus sehr seniorigen Experten mit ganz unterschiedlichen Hintergr\u00fcnden. Von Medizin \u00fcber Datenwissenschaften, Rechtswissenschaften und Co.",
        "reactions_count": 190,
        "comments_count": 21,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "1w",
        "description": "I've been giving a lot of talks to people working at the front lines of healthcare, and I'm clearly seeing a massive change in their perception of digitalization and artificial intelligence. \n\nEven in the most recent months or perhaps over the past year, it has become very clear to me that healthcare providers understand how fundamentally different the current AI era is from previous software, and there is a huge willingness to adopt new technologies, experiment, test, and contribute to their refinement \n\nHere is another really well-written article in German about the shared decision making white paper that I recently co-authored with different experts and representatives from Roche's Independent Patient Council.\n\nhttps://lnkd.in/evvD5A5p",
        "reactions_count": 107,
        "comments_count": 5,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 310,
        "date": "2w",
        "description": "Artificial intelligence is fundamentally changing how patients and clinicians work together to solve health problems in a much more personalized way than what we used to see even just a few years ago. This was a great topic our CEO Dr. Sven Jungmann discussed with a group of patient experts recently in Grenzach-Wyhlen , the beautiful German headquarter of Roche. \n\nMore on this (in German for now, English coming soon) here: https://lnkd.in/eEw_YhDK",
        "reactions_count": 8,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 48380,
        "date": "3w",
        "description": "Es ist wieder Zeit f\u00fcr neue Startups! Hier einige ganz junge Startups, die jeder kennen sollte. Heute stellen wir diese Jungunternehmen vor: aiomics, ArInLaS, bryo, Omnisent und ChangePath.\n\nhttps://lnkd.in/dE35RT29",
        "reactions_count": 4,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 310,
        "date": "1mo",
        "description": "Introducing our new digital home at aiomics\n\nToday, we're pleased to share our completely reimagined website at www.aiomics.io \u2014 a reflection of how we're approaching healthcare's documentation challenge with fresh perspective and proven technology.\n\nWhen Nikita Tarasov and I started aiomics, we set out to solve a problem every healthcare professional knows intimately: the hours lost to managing unstructured documents, the frustration of incomplete patient information, and the revenue left on the table due to documentation gaps. \n\nOur new site showcases how we're turning these challenges into opportunities for better care.\n\nWhat you'll find:\n\u2022 A clear articulation of our triple value proposition: improving patient care through better data quality, returning hours to clinical teams, and capturing revenue through accurate documentation \n\u2022 Coming soon: Detailed product pages for Symphony (our data orchestration platform) and Chorus (our AI assistant suite) that explain exactly how we transform documentation workflows \n\u2022 Coming soon: Information on our commitment to keeping humans at the center of healthcare, with AI as an amplifier of clinical expertise rather than a replacement\n\nWe've intentionally designed this site to reflect our values: no buzzwords, no unfounded promises, just practical solutions backed by research. Because healthcare professionals deserve honest partners who understand that behind every document is a patient waiting for care.\n\nFor our early partners and other forward-thinking organizations already working with us: thank you for trusting us to be part of your digital transformation journey. Your insights have shaped not just our technology, but how we communicate our mission.\n\nWe invite you to explore the new site and share your thoughts. Whether you're wrestling with documentation challenges in your own organization or simply interested in how AI can meaningfully improve healthcare operations, we'd love to hear from you.\n\nVisit us at www.aiomics.io and let's continue the conversation about building better healthcare infrastructure for Europe.\n\n#HealthcareInnovation #DigitalHealth #MedTech #HealthIT #AIinHealthcare",
        "reactions_count": 6,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 77104,
        "date": "1mo",
        "description": "Wie kann K\u00fcnstliche Intelligenz die gemeinsame Entscheidungsfindung zwischen \u00c4rzt:innen und Patient:innen unterst\u00fctzen?  \n\nAnl\u00e4sslich des bundesweiten Digitaltages 2025 stellt ein Teil des 12-k\u00f6pfigen Autorenteams das White Paper \u201cMit KI zur gemeinsamen \u00adEntscheidungsfindung in der Medizin\u201d vor. Der praktische Wegweiser zeigt an Beispielen, wie K\u00fcnstliche Intelligenz ein \u201cShared Decision Making\u201d zwischen \u00c4rzt:innen und Patient:innen unterst\u00fctzen kann.\n\n\ud83d\udca1Lead Autor und Arzt Dr. Sven Jungmann, Patientin Nele von Horsten und Anja Thelen von Roche als Projektleitung zeigen an Beispielen die Nutzung des Wegweisers. Die Moderation \u00fcbernimmt Dr. Cornelius Wittal. Eine rege Diskussion ist erw\u00fcnscht. Die Veranstaltung richtet sich an Patient:innen, Angeh\u00f6rige und \u00c4rzt:innen. \n\n\ud83d\uddd3\ufe0fVeranstaltungstag: 26.06.2025, von 12:00 Uhr bis 12:45 Uhr. Virtuelle Veranstaltung.\n\n\ud83d\udc49Zur Registrierung bitte via Online-Formular unter https://lnkd.in/e4XFA6Zp (Website cvent.com). Eine Best\u00e4tigung wird per E-Mail versandt (Absender der Best\u00e4tigungs-E-Mail ist grenzach.events at roche.com).\n\nDie \u00dcbertragung findet virtuell mit ZOOM statt. Nur die Referent:innen und der Moderator werden mit einem Videobild \u00fcbertragen. Fragen werden per Chatfunktion (F/A) mit dem Webconferencing-Tool Zoom gestellt.",
        "reactions_count": 100,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "3d",
        "description": "aiomics w\u00e4chst \u2014 wer kann Talente empfehlen? Wir suchen Head of Product, UX/UI Designer, Clinical Manager, ML Engineer (AWS und/oder NLP Fokus). Vorzugsweise Standort Berlin, aber grunds\u00e4tzlich flexibel. Muss flie\u00dfend Deutsch sprechen. Klinik oder medizinische Erfahrung von gro\u00dfem Vorteil.\u00a0Wir starten mit guter Finanzierung und mehreren gr\u00f6\u00dferen Klinikpartnern, wie auch innovativen digitalen Gesundheitsanbietern.\u00a0Es gibt jede Menge zu tun, und wir haben eine wirklich spannende Wachstumskurve vor uns.\u00a0Das Team besteht ausnahmslos aus sehr seniorigen Experten mit ganz unterschiedlichen Hintergr\u00fcnden. Von Medizin \u00fcber Datenwissenschaften, Rechtswissenschaften und Co.",
        "reactions_count": 185,
        "comments_count": 20,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "1w",
        "description": "I've been giving a lot of talks to people working at the front lines of healthcare, and I'm clearly seeing a massive change in their perception of digitalization and artificial intelligence. \n\nEven in the most recent months or perhaps over the past year, it has become very clear to me that healthcare providers understand how fundamentally different the current AI era is from previous software, and there is a huge willingness to adopt new technologies, experiment, test, and contribute to their refinement \n\nHere is another really well-written article in German about the shared decision making white paper that I recently co-authored with different experts and representatives from Roche's Independent Patient Council.\n\nhttps://lnkd.in/evvD5A5p",
        "reactions_count": 105,
        "comments_count": 5,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 182,
        "date": "2w",
        "description": "Artificial intelligence is fundamentally changing how patients and clinicians work together to solve health problems in a much more personalized way than what we used to see even just a few years ago. This was a great topic our CEO Dr. Sven Jungmann discussed with a group of patient experts recently in Grenzach-Wyhlen , the beautiful German headquarter of Roche. \n\nMore on this (in German for now, English coming soon) here: https://lnkd.in/eEw_YhDK",
        "reactions_count": 7,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 48350,
        "date": "3w",
        "description": "Es ist wieder Zeit f\u00fcr neue Startups! Hier einige ganz junge Startups, die jeder kennen sollte. Heute stellen wir diese Jungunternehmen vor: aiomics, ArInLaS, bryo, Omnisent und ChangePath.\n\nhttps://lnkd.in/dE35RT29",
        "reactions_count": 4,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 182,
        "date": "1mo",
        "description": "Introducing our new digital home at aiomics\n\nToday, we're pleased to share our completely reimagined website at www.aiomics.io \u2014 a reflection of how we're approaching healthcare's documentation challenge with fresh perspective and proven technology.\n\nWhen Nikita Tarasov and I started aiomics, we set out to solve a problem every healthcare professional knows intimately: the hours lost to managing unstructured documents, the frustration of incomplete patient information, and the revenue left on the table due to documentation gaps. \n\nOur new site showcases how we're turning these challenges into opportunities for better care.\n\nWhat you'll find:\n\u2022 A clear articulation of our triple value proposition: improving patient care through better data quality, returning hours to clinical teams, and capturing revenue through accurate documentation \n\u2022 Coming soon: Detailed product pages for Symphony (our data orchestration platform) and Chorus (our AI assistant suite) that explain exactly how we transform documentation workflows \n\u2022 Coming soon: Information on our commitment to keeping humans at the center of healthcare, with AI as an amplifier of clinical expertise rather than a replacement\n\nWe've intentionally designed this site to reflect our values: no buzzwords, no unfounded promises, just practical solutions backed by research. Because healthcare professionals deserve honest partners who understand that behind every document is a patient waiting for care.\n\nFor our early partners and other forward-thinking organizations already working with us: thank you for trusting us to be part of your digital transformation journey. Your insights have shaped not just our technology, but how we communicate our mission.\n\nWe invite you to explore the new site and share your thoughts. Whether you're wrestling with documentation challenges in your own organization or simply interested in how AI can meaningfully improve healthcare operations, we'd love to hear from you.\n\nVisit us at www.aiomics.io and let's continue the conversation about building better healthcare infrastructure for Europe.\n\n#HealthcareInnovation #DigitalHealth #MedTech #HealthIT #AIinHealthcare",
        "reactions_count": 6,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 76909,
        "date": "1mo",
        "description": "Wie kann K\u00fcnstliche Intelligenz die gemeinsame Entscheidungsfindung zwischen \u00c4rzt:innen und Patient:innen unterst\u00fctzen?  \n\nAnl\u00e4sslich des bundesweiten Digitaltages 2025 stellt ein Teil des 12-k\u00f6pfigen Autorenteams das White Paper \u201cMit KI zur gemeinsamen \u00adEntscheidungsfindung in der Medizin\u201d vor. Der praktische Wegweiser zeigt an Beispielen, wie K\u00fcnstliche Intelligenz ein \u201cShared Decision Making\u201d zwischen \u00c4rzt:innen und Patient:innen unterst\u00fctzen kann.\n\n\ud83d\udca1Lead Autor und Arzt Dr. Sven Jungmann, Patientin Nele von Horsten und Anja Thelen von Roche als Projektleitung zeigen an Beispielen die Nutzung des Wegweisers. Die Moderation \u00fcbernimmt Dr. Cornelius Wittal. Eine rege Diskussion ist erw\u00fcnscht. Die Veranstaltung richtet sich an Patient:innen, Angeh\u00f6rige und \u00c4rzt:innen. \n\n\ud83d\uddd3\ufe0fVeranstaltungstag: 26.06.2025, von 12:00 Uhr bis 12:45 Uhr. Virtuelle Veranstaltung.\n\n\ud83d\udc49Zur Registrierung bitte via Online-Formular unter https://lnkd.in/e4XFA6Zp (Website cvent.com). Eine Best\u00e4tigung wird per E-Mail versandt (Absender der Best\u00e4tigungs-E-Mail ist grenzach.events at roche.com).\n\nDie \u00dcbertragung findet virtuell mit ZOOM statt. Nur die Referent:innen und der Moderator werden mit einem Videobild \u00fcbertragen. Fragen werden per Chatfunktion (F/A) mit dem Webconferencing-Tool Zoom gestellt.",
        "reactions_count": 100,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 196,
        "date": "1mo",
        "description": "\ud83d\ude80 Remote Access Tools Market Industry\u00a02025\n\n\ud83d\udce5 \ud835\udc00\ud835\udc1c\ud835\udc1c\ud835\udc1e\ud835\udc2c\ud835\udc2c \ud835\udc0f\ud835\udc2b\ud835\udc1e\ud835\udc26\ud835\udc22\ud835\udc2e\ud835\udc26 \ud835\udc11\ud835\udc1e\ud835\udc29\ud835\udc28\ud835\udc2b\ud835\udc2d:\u00a0https://lnkd.in/eE-xuhmz\n\u00a0\nThe Remote Access Tools Market Industry is on the brink of a transformative shift, driven by innovation, evolving consumer demand, and cutting-edge advancements. As we step into 2025, businesses must stay ahead with data-driven insights to capture emerging opportunities. This is more than just a report\u2014it\u2019s a roadmap for success in 2025 and beyond. Whether you're an investor, business leader, or industry enthusiast, staying informed is the key to a competitive edge.\n\u00a0\n\ud835\udc0a\ud835\udc1e\ud835\udc32-\ud835\udc29\ud835\udc25\ud835\udc1a\ud835\udc32\ud835\udc1e\ud835\udc2b\ud835\udc2c : \n\nSynapse Product Development\u00a0\u00a0\nDigitalituM\u00a0\u00a0\nWikifactory\u00a0\u00a0\nIP Access International\u00a0\u00a0\nNoralis\u00a0\u00a0\nUnisync Group Limited, Inc.\u00a0\u00a0\nBlastWave\u00a0\u00a0\nCarbon Oral Health Applications\u00a0\u00a0\nLearning A-Z Lions\u00a0\u00a0\nC Prompt Solutions Pvt. Ltd.\u00a0\u00a0\nJM Origin\u00a0\u00a0\nTelebionix\u00a0\u00a0\nDeep Block\u00a0\u00a0\nEcount ERP\u00a0\u00a0\nCaldwell Electrical Contractors\u00a0\u00a0\nIngetrol\u00a0\u00a0\nMayfield Exploration and Production Services Limited\u00a0\u00a0\nLatitude Technologies\u00a0\u00a0\nHoover Pumping Systems\u00a0\u00a0\nPipe Vision Inspection | PVI\u00a0\u00a0\nEpoptia Cloud MES\u00a0\u00a0\nBravo Solar Energy Saudi Arabia\u00a0\u00a0\nTCIC, INC.\u00a0\u00a0\nSparks Instruments\u00a0\u00a0\ntibbo\u00a0\nDDS Company\u00a0\u00a0\nBuilding Ontario Fund Bloc Systems\u00a0\u00a0\nJobs In New Zealand And Australia Listings\u00a0\u00a0\nRaagz IT Solutions\u00a0\u00a0\nTechcare LLC (formerly Graphtech Systems)\u00a0\u00a0\nCalterion\naiomics\u00a0\u00a0\nReonix Automation Inc.\u00a0\u00a0\nMSB Accounting Solutions LLC\u00a0\u00a0\nRAPID UAV Services & Environmental Engineering Consultant\u00a0\u00a0\nNxtLevel\nPU Consulting AB | Consulting, Distribution & New Development\u00a0\u00a0\nSysgem\nSedia Biosciences Corp. (India)\u00a0\u00a0\nControl Logics\n\n\ud83d\udccc \ud835\udc0a\ud835\udc1e\ud835\udc32 \ud835\udc07\ud835\udc22\ud835\udc20\ud835\udc21\ud835\udc25\ud835\udc22\ud835\udc20\ud835\udc21\ud835\udc2d\ud835\udc2c:\n\u2705 \ud835\udc0c\ud835\udc1a\ud835\udc2b\ud835\udc24\ud835\udc1e\ud835\udc2d \ud835\udc20\ud835\udc2b\ud835\udc28\ud835\udc30\ud835\udc2d\ud835\udc21 \ud835\udc29\ud835\udc2b\ud835\udc28\ud835\udc23\ud835\udc1e\ud835\udc1c\ud835\udc2d\ud835\udc22\ud835\udc28\ud835\udc27\ud835\udc2c & \ud835\udc2d\ud835\udc2b\ud835\udc1e\ud835\udc27\ud835\udc1d\ud835\udc2c \ud83d\udcc8\n\u2705 \ud835\udc11\ud835\udc1e\ud835\udc20\ud835\udc22\ud835\udc28\ud835\udc27\ud835\udc1a\ud835\udc25 & \ud835\udc2c\ud835\udc1e\ud835\udc1c\ud835\udc2d\ud835\udc28\ud835\udc2b\ud835\udc1a\ud835\udc25 \ud835\udc22\ud835\udc27\ud835\udc2c\ud835\udc22\ud835\udc20\ud835\udc21\ud835\udc2d\ud835\udc2c \ud83c\udf0e\n\u2705 \ud835\udc02\ud835\udc28\ud835\udc26\ud835\udc29\ud835\udc1e\ud835\udc2d\ud835\udc22\ud835\udc2d\ud835\udc22\ud835\udc2f\ud835\udc1e \ud835\udc25\ud835\udc1a\ud835\udc27\ud835\udc1d\ud835\udc2c\ud835\udc1c\ud835\udc1a\ud835\udc29\ud835\udc1e & \ud835\udc24\ud835\udc1e\ud835\udc32 \ud835\udc29\ud835\udc25\ud835\udc1a\ud835\udc32\ud835\udc1e\ud835\udc2b\ud835\udc2c \ud83c\udfc6\n\u2705 \ud835\udc05\ud835\udc2e\ud835\udc2d\ud835\udc2e\ud835\udc2b\ud835\udc1e \ud835\udc28\ud835\udc29\ud835\udc29\ud835\udc28\ud835\udc2b\ud835\udc2d\ud835\udc2e\ud835\udc27\ud835\udc22\ud835\udc2d\ud835\udc22\ud835\udc1e\ud835\udc2c & \ud835\udc1c\ud835\udc21\ud835\udc1a\ud835\udc25\ud835\udc25\ud835\udc1e\ud835\udc27\ud835\udc20\ud835\udc1e\ud835\udc2c \ud83d\udd0d\n\u00a0\n#RemoteAccessTools #RemoteAccessToolsMarket #MarketTrends #BusinessGrowth #IndustryInsights #MarketResearch #Innovation #Management #DigitalMarketing #Technology #Creativity #Futurism #Startups #Marketing #SocialMedia #SocialNetworking",
        "reactions_count": 4,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 182,
        "date": "1mo",
        "description": "Two startup reality checks from our journey:\nFirst: Everyone talks about building solutions with end users, but in healthcare, getting genuine access to clinical teams who can dedicate time to co-creation is incredibly challenging.\n\nSecond: German hospitals have a reputation for being slow to adopt new technologies. Just a few months ago, we couldn't have imagined we'd be spending most of our time building directly with hospital teams.\n\nBut something has shifted. Healthcare organizations are now actively seeking innovation partners, and MEDICLIN under Dr. Christian Dohmen-Griesenbach's leadership is pioneering this change.\n\nWhat makes this partnership remarkable is the depth of collaboration. Linda Pistor, Dr. Dimitrios Artemis, Prof. Dr. Philipp H\u00fcllemann, Dr. Max Holger Warnke, Dr. Florian Weber, and their colleagues aren't just stakeholders providing occasional feedback. They're opening up their workflows, sharing their daily  challenges with documentation, and actively shaping how our infrastructure evolves.\n\nWe're learning from the field what rehabilitation physicians need during admissions, how nurses navigate between systems, what information therapists actually need for treatment planning, and what legally mandated compliance tasks are keeping staff away from meaningful patient interactions. This isn't theoretical user research \u2013 it's building alongside the people who know exactly where technology can make the biggest difference.\n\nThe readiness for change we're witnessing at MEDICLIN signals something bigger: German healthcare is ready to pick up significant pace in digital transformation.\n\nMore insights from this collaboration coming soon.\n\n#StartupLessons #HealthTech #GermanHealthcare #DigitalTransformation",
        "reactions_count": 1,
        "comments_count": 2,
        "reshared_post_author": "Dr. Christian Dohmen-Griesenbach",
        "reshared_post_author_url": "https://de.linkedin.com/in/dr-christian-dohmen-griesenbach-3057a815b",
        "reshared_post_author_headline": "Leiter KI und Digitale Transformation bei der MEDICLIN Management GmbH & Co. KG | Ideentreiber f\u00fcr die Zukunft des Gesundheitswesens",
        "reshared_post_description": "\ud83d\udca1 Pfingsten, Heiliger Geist und die digitale Erleuchtung im Gesundheitswesen\n\nPfingsten steht traditionell f\u00fcr Inspiration, Aufbruch \u2013 und den \u201eHeiligen Geist\u201c als Impulsgeber f\u00fcr Verst\u00e4ndigung und Ver\u00e4nderung. Ein passender Anlass, um \u00fcber strukturelle Erneuerung im Gesundheitswesen nachzudenken.\n\n\ud83e\udde0 Der aktuelle Interview-Beitrag mit dem Arzt und KI-Experten Dr. Sven Jungmann im FOCUS zur Rolle von KI in der Medizin bringt zentrale Gedanken auf den Punkt:\n\n\u2022 KI ist kein Ersatz, sondern ein Werkzeug, um \u00e4rztliches Denken zu erweitern.\n\u2022 Der Einstieg gelingt \u00fcber pragmatische Automatisierungen \u2013 etwa in der Dokumentation und Prozessstruktur.\n\u2022 Die Grundlage bleibt: saubere, vielf\u00e4ltige und vernetzte Daten.\n\nhttps://lnkd.in/ehksfPtC\n\n\ud83d\udee0\ufe0f Genau hier setzen wir auch bei #MEDICLIN gemeinsam mit Sven in einem zentralen Projekt an. Dort befassen wir uns mit der automatisierten Strukturierung gro\u00dfer Mengen klinischer Informationen \u2013 aus Vorsystemen, von Papier und aus unstrukturierten Formaten. Ziel ist es, diese Daten f\u00fcr eine intelligente Weiterverarbeitung verf\u00fcgbar zu machen: schneller, nachvollziehbarer, nutzbar f\u00fcr Patientenversorgung und Entscheidungsunterst\u00fctzung und Entlastung. Und nat\u00fcrlich folgt dieses Projekt einer Gesamtstrategie.\n\n\ud83e\udd1d Besonders wichtig:\nDieses Projekt entsteht nicht top-down, sondern wird aus der klinischen Praxis heraus gestaltet \u2013 gemeinsam mit \u00c4rzten, Therapeuten, Pflegekr\u00e4ften, Qualit\u00e4tsmanagern und Kaufleuten. Die digitale Transformation wird dadurch konkreter, anschlussf\u00e4higer und nachhaltiger. Deshalb ein gro\u00dfer Dank an Linda Pistor, Dr. Dimitrios Artemis, Prof. Dr. Philipp H\u00fcllemann, Dr. Max Holger Warnke, Dr. Florian Weber u.v.m. \u00fcber den Blick hinter die Kulissen der Reha von heute. Wer sich noch am Projekt beteiligen m\u00f6chte, kann sich gerne bei mir melden!\n\n\ud83c\udf2c\ufe0f Pfingsten als Fest der Verst\u00e4ndigung erinnert uns daran, dass Fortschritt dort gelingt, wo wir Komplexit\u00e4t in Struktur \u00fcberf\u00fchren \u2013 mit digitalen Mitteln, aber im Dienst eines menschlichen Gesundheitswesens.\n\n#DigitaleGesundheit #KIinderReha #BottomUpInnovation #Pfingsten2025",
        "reshared_post_date": "1mo",
        "reshared_post_followers": null
      },
      {
        "followers": 182,
        "date": "3mo",
        "description": "Milestone Achievement: Aiomics\u00ae Recognized by BAFA INVEST Zuschuss Program\nWe're pleased to share that we have been approved for the BAFA INVEST Zuschuss program by the German Federal Office for Economic Affairs and Export Control (BAFA). This recognition formally classifies us as a \"young innovative company\" within the German startup ecosystem.\n\nWhat is the BAFA INVEST Zuschuss?\nFor those unfamiliar with this program, it represents a strategic initiative by the German government to stimulate investment in innovative early-stage companies. The program functions as a de facto government endorsement of a startup's innovation potential and business model viability.\n\nThe Significance Beyond Financial Benefits\nThis approval process involves an independent evaluation of our company conducted by federal authorities.\n\nThis designation carries three key implications:\n\n1. External Validation: It provides independent verification of our innovation claims and business model from government experts who evaluate hundreds of companies annually.\n2. Risk Mitigation for Investors: The program offers private investors a 15% reimbursement on their investment and a 25% reimbursement on their exit sum, effectively improving the risk-return profile of investing in our company.\n3. Ecosystem Recognition: It positions us within Germany's formal innovation framework, potentially opening doors to additional innovation-focused resources, partnerships, and networks.\n\nWe see this milestone not merely as a financial incentive mechanism, but as validation of our team's hard work and our strategic direction. And we're pleased to be able to sweeten the deal for our ever so supportive investors, many of which have been an integral part of Dr. Sven Jungmann's previous journey(s). \n\nWe're grateful for this recognition and look forward to delivering on the innovative potential that this designation acknowledges.\n\n#Innovation #StartupGrowth #GermanTech #BAFA #aiomics",
        "reactions_count": 39,
        "comments_count": 2,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 113,
        "date": "12h",
        "description": "Artificial intelligence is fundamentally changing how patients and clinicians work together to solve health problems in a much more personalized way than what we used to see even just a few years ago. This was a great topic our CEO Dr. Sven Jungmann discussed with a group of patient experts recently in Grenzach-Wyhlen , the beautiful German headquarter of Roche. \n\nMore on this (in German for now, English coming soon) here: https://lnkd.in/eEw_YhDK",
        "reactions_count": null,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 48301,
        "date": "1w",
        "description": "Es ist wieder Zeit f\u00fcr neue Startups! Hier einige ganz junge Startups, die jeder kennen sollte. Heute stellen wir diese Jungunternehmen vor: aiomics, ArInLaS, bryo, Omnisent und ChangePath.\n\nhttps://lnkd.in/dE35RT29",
        "reactions_count": 1,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 113,
        "date": "3w",
        "description": "Introducing our new digital home at aiomics\n\nToday, we're pleased to share our completely reimagined website at www.aiomics.io \u2014 a reflection of how we're approaching healthcare's documentation challenge with fresh perspective and proven technology.\n\nWhen Nikita Tarasov and I started aiomics, we set out to solve a problem every healthcare professional knows intimately: the hours lost to managing unstructured documents, the frustration of incomplete patient information, and the revenue left on the table due to documentation gaps. \n\nOur new site showcases how we're turning these challenges into opportunities for better care.\n\nWhat you'll find:\n\u2022 A clear articulation of our triple value proposition: improving patient care through better data quality, returning hours to clinical teams, and capturing revenue through accurate documentation \n\u2022 Coming soon: Detailed product pages for Symphony (our data orchestration platform) and Chorus (our AI assistant suite) that explain exactly how we transform documentation workflows \n\u2022 Coming soon: Information on our commitment to keeping humans at the center of healthcare, with AI as an amplifier of clinical expertise rather than a replacement\n\nWe've intentionally designed this site to reflect our values: no buzzwords, no unfounded promises, just practical solutions backed by research. Because healthcare professionals deserve honest partners who understand that behind every document is a patient waiting for care.\n\nFor our early partners and other forward-thinking organizations already working with us: thank you for trusting us to be part of your digital transformation journey. Your insights have shaped not just our technology, but how we communicate our mission.\n\nWe invite you to explore the new site and share your thoughts. Whether you're wrestling with documentation challenges in your own organization or simply interested in how AI can meaningfully improve healthcare operations, we'd love to hear from you.\n\nVisit us at www.aiomics.io and let's continue the conversation about building better healthcare infrastructure for Europe.\n\n#HealthcareInnovation #DigitalHealth #MedTech #HealthIT #AIinHealthcare",
        "reactions_count": 6,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 75739,
        "date": "3w",
        "description": "Wie kann K\u00fcnstliche Intelligenz die gemeinsame Entscheidungsfindung zwischen \u00c4rzt:innen und Patient:innen unterst\u00fctzen?  \n\nAnl\u00e4sslich des bundesweiten Digitaltages 2025 stellt ein Teil des 12-k\u00f6pfigen Autorenteams das White Paper \u201cMit KI zur gemeinsamen \u00adEntscheidungsfindung in der Medizin\u201d vor. Der praktische Wegweiser zeigt an Beispielen, wie K\u00fcnstliche Intelligenz ein \u201cShared Decision Making\u201d zwischen \u00c4rzt:innen und Patient:innen unterst\u00fctzen kann.\n\n\ud83d\udca1Lead Autor und Arzt Dr. Sven Jungmann, Patientin Nele von Horsten und Anja Thelen von Roche als Projektleitung zeigen an Beispielen die Nutzung des Wegweisers. Die Moderation \u00fcbernimmt Dr. Cornelius Wittal. Eine rege Diskussion ist erw\u00fcnscht. Die Veranstaltung richtet sich an Patient:innen, Angeh\u00f6rige und \u00c4rzt:innen. \n\n\ud83d\uddd3\ufe0fVeranstaltungstag: 26.06.2025, von 12:00 Uhr bis 12:45 Uhr. Virtuelle Veranstaltung.\n\n\ud83d\udc49Zur Registrierung bitte via Online-Formular unter https://lnkd.in/e4XFA6Zp (Website cvent.com). Eine Best\u00e4tigung wird per E-Mail versandt (Absender der Best\u00e4tigungs-E-Mail ist grenzach.events at roche.com).\n\nDie \u00dcbertragung findet virtuell mit ZOOM statt. Nur die Referent:innen und der Moderator werden mit einem Videobild \u00fcbertragen. Fragen werden per Chatfunktion (F/A) mit dem Webconferencing-Tool Zoom gestellt.",
        "reactions_count": 98,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "1mo",
        "description": "\ud83c\udfe5 ML Engineer Opportunity: Build AI Infrastructure for European Healthcare \ud83c\udfe5\n\nWe're looking for an ML Engineer based in Germany to join our international team at aiomics. If you know someone great\u2014or if this sounds like you\u2014please reach out directly. \ud83d\ude4b\u2642\ufe0f \n\nWhat we're building: We're currently implementing our AI platform across 7 hospital facilities with advanced medical services. Our product is designed to save medical teams hours daily on documentation, using that time for meaningful patient care instead while having much better information on their patients. Our early hospital partners alone could reach 5M patients annually\u2014and we are only getting started. There have several more implementations in preparation right now.\n\nWhat we're working on: \n\u2022 Building ML systems that process unstructured medical data in various languages\u2014from handwritten notes to discharge letters to lab reports \n\u2022 Developing intelligent document extraction and structuring with ICD-10/SNOMED CT coding \n\u2022 Creating AI assistants that help draft all sorts of medical documentation, patient education material, and insurance and compliance forms \n\u2022 Designing for real-world healthcare: multilingual processing (24+ languages), GDPR/MDR compliance built in \n\u2022 Working on challenging NLP problems specific to European medical language patterns\n\nYou'll work directly with our CTO Nikita Tarasov on core infrastructure decisions and implement the latest ML technologies in a compliant manner. No competing projects\u2014just one product, built right.\n\nOur team: 5 core members from different countries, speaking 9 languages collectively. I'm a doctor-turned-founder, bringing healthcare expertise to technical decisions. We reason from first principles, move fast, remove roadblocks efficiently, and build solid foundations\u2014no shortcuts on quality.\n\nRequirements: \n\u2022 Work authorization in Germany \n\u2022 Drive to transform healthcare through technology\n\u2022 German language skills valuable (other European languages also great) \n\nWe prefer warm introductions\u2014no recruiters please. Join us in giving healthcare professionals their time back and enabling them to do what made them choose this profession in the first place: being there for their patients.\n\n#MachineLearning #HealthTech #MLJobs #GermanyJobs #AIEngineering",
        "reactions_count": 77,
        "comments_count": 8,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 190,
        "date": "1mo",
        "description": "\ud83d\ude80 Remote Access Tools Market Industry\u00a02025\n\n\ud83d\udce5 \ud835\udc00\ud835\udc1c\ud835\udc1c\ud835\udc1e\ud835\udc2c\ud835\udc2c \ud835\udc0f\ud835\udc2b\ud835\udc1e\ud835\udc26\ud835\udc22\ud835\udc2e\ud835\udc26 \ud835\udc11\ud835\udc1e\ud835\udc29\ud835\udc28\ud835\udc2b\ud835\udc2d:\u00a0https://lnkd.in/eE-xuhmz\n\u00a0\nThe Remote Access Tools Market Industry is on the brink of a transformative shift, driven by innovation, evolving consumer demand, and cutting-edge advancements. As we step into 2025, businesses must stay ahead with data-driven insights to capture emerging opportunities. This is more than just a report\u2014it\u2019s a roadmap for success in 2025 and beyond. Whether you're an investor, business leader, or industry enthusiast, staying informed is the key to a competitive edge.\n\u00a0\n\ud835\udc0a\ud835\udc1e\ud835\udc32-\ud835\udc29\ud835\udc25\ud835\udc1a\ud835\udc32\ud835\udc1e\ud835\udc2b\ud835\udc2c : \n\nSynapse Product Development\u00a0\u00a0\nDigitalituM\u00a0\u00a0\nWikifactory\u00a0\u00a0\nIP Access International\u00a0\u00a0\nNoralis\u00a0\u00a0\nUnisync Group Limited, Inc.\u00a0\u00a0\nBlastWave\u00a0\u00a0\nCarbon Oral Health Applications\u00a0\u00a0\nLearning A-Z Lions\u00a0\u00a0\nC Prompt Solutions Pvt. Ltd.\u00a0\u00a0\nJM Origin\u00a0\u00a0\nTelebionix\u00a0\u00a0\nDeep Block\u00a0\u00a0\nEcount ERP\u00a0\u00a0\nCaldwell Electrical Contractors\u00a0\u00a0\nIngetrol\u00a0\u00a0\nMayfield Exploration and Production Services Limited\u00a0\u00a0\nLatitude Technologies\u00a0\u00a0\nHoover Pumping Systems\u00a0\u00a0\nPipe Vision Inspection | PVI\u00a0\u00a0\nEpoptia Cloud MES\u00a0\u00a0\nBravo Solar Energy Saudi Arabia\u00a0\u00a0\nTCIC, INC.\u00a0\u00a0\nSparks Instruments\u00a0\u00a0\ntibbo\u00a0\nDDS Company\u00a0\u00a0\nBuilding Ontario Fund Bloc Systems\u00a0\u00a0\nJobs In New Zealand And Australia Listings\u00a0\u00a0\nRaagz IT Solutions\u00a0\u00a0\nTechcare LLC (formerly Graphtech Systems)\u00a0\u00a0\nCalterion\naiomics\u00a0\u00a0\nReonix Automation Inc.\u00a0\u00a0\nMSB Accounting Solutions LLC\u00a0\u00a0\nRAPID UAV Services & Environmental Engineering Consultant\u00a0\u00a0\nNxtLevel\nPU Consulting AB | Consulting, Distribution & New Development\u00a0\u00a0\nSysgem\nSedia Biosciences Corp. (India)\u00a0\u00a0\nControl Logics\n\n\ud83d\udccc \ud835\udc0a\ud835\udc1e\ud835\udc32 \ud835\udc07\ud835\udc22\ud835\udc20\ud835\udc21\ud835\udc25\ud835\udc22\ud835\udc20\ud835\udc21\ud835\udc2d\ud835\udc2c:\n\u2705 \ud835\udc0c\ud835\udc1a\ud835\udc2b\ud835\udc24\ud835\udc1e\ud835\udc2d \ud835\udc20\ud835\udc2b\ud835\udc28\ud835\udc30\ud835\udc2d\ud835\udc21 \ud835\udc29\ud835\udc2b\ud835\udc28\ud835\udc23\ud835\udc1e\ud835\udc1c\ud835\udc2d\ud835\udc22\ud835\udc28\ud835\udc27\ud835\udc2c & \ud835\udc2d\ud835\udc2b\ud835\udc1e\ud835\udc27\ud835\udc1d\ud835\udc2c \ud83d\udcc8\n\u2705 \ud835\udc11\ud835\udc1e\ud835\udc20\ud835\udc22\ud835\udc28\ud835\udc27\ud835\udc1a\ud835\udc25 & \ud835\udc2c\ud835\udc1e\ud835\udc1c\ud835\udc2d\ud835\udc28\ud835\udc2b\ud835\udc1a\ud835\udc25 \ud835\udc22\ud835\udc27\ud835\udc2c\ud835\udc22\ud835\udc20\ud835\udc21\ud835\udc2d\ud835\udc2c \ud83c\udf0e\n\u2705 \ud835\udc02\ud835\udc28\ud835\udc26\ud835\udc29\ud835\udc1e\ud835\udc2d\ud835\udc22\ud835\udc2d\ud835\udc22\ud835\udc2f\ud835\udc1e \ud835\udc25\ud835\udc1a\ud835\udc27\ud835\udc1d\ud835\udc2c\ud835\udc1c\ud835\udc1a\ud835\udc29\ud835\udc1e & \ud835\udc24\ud835\udc1e\ud835\udc32 \ud835\udc29\ud835\udc25\ud835\udc1a\ud835\udc32\ud835\udc1e\ud835\udc2b\ud835\udc2c \ud83c\udfc6\n\u2705 \ud835\udc05\ud835\udc2e\ud835\udc2d\ud835\udc2e\ud835\udc2b\ud835\udc1e \ud835\udc28\ud835\udc29\ud835\udc29\ud835\udc28\ud835\udc2b\ud835\udc2d\ud835\udc2e\ud835\udc27\ud835\udc22\ud835\udc2d\ud835\udc22\ud835\udc1e\ud835\udc2c & \ud835\udc1c\ud835\udc21\ud835\udc1a\ud835\udc25\ud835\udc25\ud835\udc1e\ud835\udc27\ud835\udc20\ud835\udc1e\ud835\udc2c \ud83d\udd0d\n\u00a0\n#RemoteAccessTools #RemoteAccessToolsMarket #MarketTrends #BusinessGrowth #IndustryInsights #MarketResearch #Innovation #Management #DigitalMarketing #Technology #Creativity #Futurism #Startups #Marketing #SocialMedia #SocialNetworking",
        "reactions_count": 4,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 113,
        "date": "1mo",
        "description": "Two startup reality checks from our journey:\nFirst: Everyone talks about building solutions with end users, but in healthcare, getting genuine access to clinical teams who can dedicate time to co-creation is incredibly challenging.\n\nSecond: German hospitals have a reputation for being slow to adopt new technologies. Just a few months ago, we couldn't have imagined we'd be spending most of our time building directly with hospital teams.\n\nBut something has shifted. Healthcare organizations are now actively seeking innovation partners, and MEDICLIN under Dr. Christian Dohmen-Griesenbach's leadership is pioneering this change.\n\nWhat makes this partnership remarkable is the depth of collaboration. Linda Pistor, Dr. Dimitrios Artemis, Prof. Dr. Philipp H\u00fcllemann, Dr. Max Holger Warnke, Dr. Florian Weber, and their colleagues aren't just stakeholders providing occasional feedback. They're opening up their workflows, sharing their daily  challenges with documentation, and actively shaping how our infrastructure evolves.\n\nWe're learning from the field what rehabilitation physicians need during admissions, how nurses navigate between systems, what information therapists actually need for treatment planning, and what legally mandated compliance tasks are keeping staff away from meaningful patient interactions. This isn't theoretical user research \u2013 it's building alongside the people who know exactly where technology can make the biggest difference.\n\nThe readiness for change we're witnessing at MEDICLIN signals something bigger: German healthcare is ready to pick up significant pace in digital transformation.\n\nMore insights from this collaboration coming soon.\n\n#StartupLessons #HealthTech #GermanHealthcare #DigitalTransformation",
        "reactions_count": 1,
        "comments_count": 2,
        "reshared_post_author": "Dr. Christian Dohmen-Griesenbach",
        "reshared_post_author_url": "https://de.linkedin.com/in/dr-christian-dohmen-griesenbach-3057a815b",
        "reshared_post_author_headline": "Leiter KI und Digitale Transformation bei der MEDICLIN Management GmbH & Co. KG | Ideentreiber f\u00fcr die Zukunft des Gesundheitswesens",
        "reshared_post_description": "\ud83d\udca1 Pfingsten, Heiliger Geist und die digitale Erleuchtung im Gesundheitswesen\n\nPfingsten steht traditionell f\u00fcr Inspiration, Aufbruch \u2013 und den \u201eHeiligen Geist\u201c als Impulsgeber f\u00fcr Verst\u00e4ndigung und Ver\u00e4nderung. Ein passender Anlass, um \u00fcber strukturelle Erneuerung im Gesundheitswesen nachzudenken.\n\n\ud83e\udde0 Der aktuelle Interview-Beitrag mit dem Arzt und KI-Experten Dr. Sven Jungmann im FOCUS zur Rolle von KI in der Medizin bringt zentrale Gedanken auf den Punkt:\n\n\u2022 KI ist kein Ersatz, sondern ein Werkzeug, um \u00e4rztliches Denken zu erweitern.\n\u2022 Der Einstieg gelingt \u00fcber pragmatische Automatisierungen \u2013 etwa in der Dokumentation und Prozessstruktur.\n\u2022 Die Grundlage bleibt: saubere, vielf\u00e4ltige und vernetzte Daten.\n\nhttps://lnkd.in/ehksfPtC\n\n\ud83d\udee0\ufe0f Genau hier setzen wir auch bei #MEDICLIN gemeinsam mit Sven in einem zentralen Projekt an. Dort befassen wir uns mit der automatisierten Strukturierung gro\u00dfer Mengen klinischer Informationen \u2013 aus Vorsystemen, von Papier und aus unstrukturierten Formaten. Ziel ist es, diese Daten f\u00fcr eine intelligente Weiterverarbeitung verf\u00fcgbar zu machen: schneller, nachvollziehbarer, nutzbar f\u00fcr Patientenversorgung und Entscheidungsunterst\u00fctzung und Entlastung. Und nat\u00fcrlich folgt dieses Projekt einer Gesamtstrategie.\n\n\ud83e\udd1d Besonders wichtig:\nDieses Projekt entsteht nicht top-down, sondern wird aus der klinischen Praxis heraus gestaltet \u2013 gemeinsam mit \u00c4rzten, Therapeuten, Pflegekr\u00e4ften, Qualit\u00e4tsmanagern und Kaufleuten. Die digitale Transformation wird dadurch konkreter, anschlussf\u00e4higer und nachhaltiger. Deshalb ein gro\u00dfer Dank an Linda Pistor, Dr. Dimitrios Artemis, Prof. Dr. Philipp H\u00fcllemann, Dr. Max Holger Warnke, Dr. Florian Weber u.v.m. \u00fcber den Blick hinter die Kulissen der Reha von heute. Wer sich noch am Projekt beteiligen m\u00f6chte, kann sich gerne bei mir melden!\n\n\ud83c\udf2c\ufe0f Pfingsten als Fest der Verst\u00e4ndigung erinnert uns daran, dass Fortschritt dort gelingt, wo wir Komplexit\u00e4t in Struktur \u00fcberf\u00fchren \u2013 mit digitalen Mitteln, aber im Dienst eines menschlichen Gesundheitswesens.\n\n#DigitaleGesundheit #KIinderReha #BottomUpInnovation #Pfingsten2025",
        "reshared_post_date": "1mo",
        "reshared_post_followers": null
      },
      {
        "followers": 113,
        "date": "2mo",
        "description": "Milestone Achievement: Aiomics\u00ae Recognized by BAFA INVEST Zuschuss Program\nWe're pleased to share that we have been approved for the BAFA INVEST Zuschuss program by the German Federal Office for Economic Affairs and Export Control (BAFA). This recognition formally classifies us as a \"young innovative company\" within the German startup ecosystem.\n\nWhat is the BAFA INVEST Zuschuss?\nFor those unfamiliar with this program, it represents a strategic initiative by the German government to stimulate investment in innovative early-stage companies. The program functions as a de facto government endorsement of a startup's innovation potential and business model viability.\n\nThe Significance Beyond Financial Benefits\nThis approval process involves an independent evaluation of our company conducted by federal authorities.\n\nThis designation carries three key implications:\n\n1. External Validation: It provides independent verification of our innovation claims and business model from government experts who evaluate hundreds of companies annually.\n2. Risk Mitigation for Investors: The program offers private investors a 15% reimbursement on their investment and a 25% reimbursement on their exit sum, effectively improving the risk-return profile of investing in our company.\n3. Ecosystem Recognition: It positions us within Germany's formal innovation framework, potentially opening doors to additional innovation-focused resources, partnerships, and networks.\n\nWe see this milestone not merely as a financial incentive mechanism, but as validation of our team's hard work and our strategic direction. And we're pleased to be able to sweeten the deal for our ever so supportive investors, many of which have been an integral part of Dr. Sven Jungmann's previous journey(s). \n\nWe're grateful for this recognition and look forward to delivering on the innovative potential that this designation acknowledges.\n\n#Innovation #StartupGrowth #GermanTech #BAFA #aiomics",
        "reactions_count": 39,
        "comments_count": 2,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "2mo",
        "description": "In drei Wochen ist es endlich so weit Dr. Tina Wenz Philipp Koch Dr. Sven Jungmann Jeremy D\u00e4hn Charlene Nowotny Nico Vogler Daniel Dominik Hecht Seroton Minddistrict DACH POLYPOINT Deutschland GmbH Healex DMI GmbH & Co. KG u.v.a.m. \ud83d\ude80\ud83d\ude80\ud83e\udd16\ud83e\udd16\ud83d\ude0e\ud83d\ude0e Freu mich drauf! Schon jetzt ein Spoiler: Wir werden definitiv mehr an den Potenzialen arbeiten als an Risiken, denn Bremser und Bedenkentr\u00e4ger gibt\u2018s hierzulande schon zu gen\u00fcge \ud83d\ude09",
        "reactions_count": 38,
        "comments_count": 9,
        "reshared_post_author": "Deutsches Psychiatrieforum e.V.",
        "reshared_post_author_url": "https://de.linkedin.com/company/deutsches-psychiatrieforum-e-v",
        "reshared_post_author_headline": null,
        "reshared_post_description": "\ud83d\udce3 Innovative Ans\u00e4tze und Expertenwissen: Seien Sie dabei! \nWir laden Sie herzlich zu unseren inspirierenden Workshops im Rahmen der Fachtagung am Donnerstagnachmittag ein. Diese Veranstaltung bietet Ihnen die perfekte Plattform, um Ihr Wissen zu erweitern und sich mit Gleichgesinnten auszutauschen.\n\n\ud83d\udd0d Was erwartet Sie?\nHochkar\u00e4tige Referenten:\u00a0Profitieren Sie von den Erfahrungen und dem Wissen f\u00fchrender Experten im Bereich Psychiatrie.\nInteraktive Sessions:\u00a0Tauchen Sie ein in praxisnahe Workshops, die Ihnen sofort umsetzbare Strategien und neueste Forschungsergebnisse bieten.\nNetzwerk-M\u00f6glichkeiten:\u00a0Nutzen Sie die Chance, wertvolle Kontakte zu kn\u00fcpfen und Ihr berufliches Netzwerk zu erweitern.\n\n\ud83c\udfaf Sichern Sie sich Ihren Platz! Der Link zum detaillierten Programm und zur Anmeldung finden Sie in den Kommentaren. Wir freuen uns darauf, Sie bei unseren Workshops begr\u00fc\u00dfen zu d\u00fcrfen und gemeinsam neue Horizonte zu erkunden.\n\n#Psychiatrie #Fachtagung #Workshops #Weiterbildung #Netzwerken #Innovation",
        "reshared_post_date": "3mo",
        "reshared_post_followers": null
      },
      {
        "followers": 3620,
        "date": "3mo",
        "description": "\ud83d\udea8 \ud835\udde0\ud835\uddfc\ud835\uddff\ud835\uddfd\ud835\uddf5\ud835\udde5\ud835\uddee\ud835\uddf1\ud835\uddee\ud835\uddff \u2013 \ud835\udde7\ud835\uddfc\ud835\uddfd \ud835\udfef \ud835\udde6\ud835\ude01\ud835\uddee\ud835\uddff\ud835\ude01\ud835\ude02\ud835\uddfd\ud835\ude00 \ud835\uddfc\ud835\uddf3 \ud835\ude01\ud835\uddf5\ud835\uddf2 \ud835\uddea\ud835\uddf2\ud835\uddf2\ud835\uddf8 \ud83d\udea8 \n\nWe hope your portfolio is doing fine. \ud83d\udc40\n\nSeriously:\u00a0While the market currently feels like an on/off situationship,\u00a0there is at least one constant you can count on in your life \u2013\u00a0the weekly\u00a0\ud835\udde0\ud835\uddfc\ud835\uddfb\ud835\uddf1\ud835\uddee\ud835\ude06 \ud835\udde0\ud835\uddfc\ud835\uddff\ud835\uddfd\ud835\uddf5\ud835\uddee\ud835\uddf6\ud835\ude00 \ud835\udde3\ud835\uddfc\ud835\ude00\ud835\ude01.\u00a0\ud83d\ude0e\n\nThis week, we have uploaded\u00a0\ud835\udfee\ud835\udfed\ud835\udfef \ud835\uddfb\ud835\uddf2\ud835\ude04 \ud835\uddf1\ud835\uddf2\ud835\uddee\ud835\uddf9\ud835\ude00\u00a0(including\u00a0\ud835\udff0\ud835\udfef \ud835\ude00\ud835\ude01\ud835\uddf2\ud835\uddee\ud835\uddf9\ud835\ude01\ud835\uddf5 \ud835\uddf3\ud835\uddfc\ud835\ude02\ud835\uddfb\ud835\uddf1\ud835\uddf2\ud835\uddff\ud835\ude00) from\u00a0\ud835\udfed\ud835\udff4 \ud835\uddf0\ud835\uddfc\ud835\ude02\ud835\uddfb\ud835\ude01\ud835\uddff\ud835\uddf6\ud835\uddf2\ud835\ude00\u00a0to our platform,\u00a0with a focus on some really\u00a0\ud835\ude00\ud835\uddfa\ud835\uddee\ud835\uddff\ud835\ude01 \ud835\udde3\ud835\uddf5\ud835\uddd7 \ud835\uddf3\ud835\uddfc\ud835\ude02\ud835\uddfb\ud835\uddf1\ud835\uddf2\ud835\uddff\ud835\ude00\u00a0from\u00a0the BioTech and MedTech space. \ud83d\udc68\ud83c\udffb\ud83d\udd2c\ud83e\uddec\n\nSee our\u00a0\ud835\udde7\ud835\uddfc\ud835\uddfd \ud835\udfef \ud835\uddd7\ud835\uddf2\ud835\uddee\ud835\uddf9\ud835\ude00\u00a0of the week down below! \u2b07\ufe0f\n\n---\n\n(1) \ud83c\udde9\ud83c\uddea aiomics (Dr. Sven Jungmann, Nikita Tarasov & Karim Galzahr)\n(2) \ud83c\uddec\ud83c\udde7 Aethox Therapeutics (Charles Spicer, James Arnold & Khondaker Miraz Rahman)\n(3) \ud83c\udde9\ud83c\uddea Stealth Founder: Christoph Sch\u00fctte\n\nGet \ud835\udfee\ud835\udfec\ud835\udfec+ \ud835\uddf1\ud835\uddf2\ud835\uddee\ud835\uddf9\ud835\ude00\u00a0on a weekly basis - get started with our newsletter and our Free Demo today. Links are in the comments! \u2b07\ufe0f",
        "reactions_count": 15,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 103,
        "date": "1w",
        "description": "Introducing our new digital home at aiomics\n\nToday, we're pleased to share our completely reimagined website at www.aiomics.io \u2014 a reflection of how we're approaching healthcare's documentation challenge with fresh perspective and proven technology.\n\nWhen Nikita Tarasov and I started aiomics, we set out to solve a problem every healthcare professional knows intimately: the hours lost to managing unstructured documents, the frustration of incomplete patient information, and the revenue left on the table due to documentation gaps. \n\nOur new site showcases how we're turning these challenges into opportunities for better care.\n\nWhat you'll find:\n\u2022 A clear articulation of our triple value proposition: improving patient care through better data quality, returning hours to clinical teams, and capturing revenue through accurate documentation \n\u2022 Coming soon: Detailed product pages for Symphony (our data orchestration platform) and Chorus (our AI assistant suite) that explain exactly how we transform documentation workflows \n\u2022 Coming soon: Information on our commitment to keeping humans at the center of healthcare, with AI as an amplifier of clinical expertise rather than a replacement\n\nWe've intentionally designed this site to reflect our values: no buzzwords, no unfounded promises, just practical solutions backed by research. Because healthcare professionals deserve honest partners who understand that behind every document is a patient waiting for care.\n\nFor our early partners and other forward-thinking organizations already working with us: thank you for trusting us to be part of your digital transformation journey. Your insights have shaped not just our technology, but how we communicate our mission.\n\nWe invite you to explore the new site and share your thoughts. Whether you're wrestling with documentation challenges in your own organization or simply interested in how AI can meaningfully improve healthcare operations, we'd love to hear from you.\n\nVisit us at www.aiomics.io and let's continue the conversation about building better healthcare infrastructure for Europe.\n\n#HealthcareInnovation #DigitalHealth #MedTech #HealthIT #AIinHealthcare",
        "reactions_count": 5,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 74495,
        "date": "1w",
        "description": "Wie kann K\u00fcnstliche Intelligenz die gemeinsame Entscheidungsfindung zwischen \u00c4rzt:innen und Patient:innen unterst\u00fctzen?  \n\nAnl\u00e4sslich des bundesweiten Digitaltages 2025 stellt ein Teil des 12-k\u00f6pfigen Autorenteams das White Paper \u201cMit KI zur gemeinsamen \u00adEntscheidungsfindung in der Medizin\u201d vor. Der praktische Wegweiser zeigt an Beispielen, wie K\u00fcnstliche Intelligenz ein \u201cShared Decision Making\u201d zwischen \u00c4rzt:innen und Patient:innen unterst\u00fctzen kann.\n\n\ud83d\udca1Lead Autor und Arzt Dr. Sven Jungmann, Patientin Nele von Horsten und Anja Thelen von Roche als Projektleitung zeigen an Beispielen die Nutzung des Wegweisers. Die Moderation \u00fcbernimmt Dr. Cornelius Wittal. Eine rege Diskussion ist erw\u00fcnscht. Die Veranstaltung richtet sich an Patient:innen, Angeh\u00f6rige und \u00c4rzt:innen. \n\n\ud83d\uddd3\ufe0fVeranstaltungstag: 26.06.2025, von 12:00 Uhr bis 12:45 Uhr. Virtuelle Veranstaltung.\n\n\ud83d\udc49Zur Registrierung bitte via Online-Formular unter https://lnkd.in/e4XFA6Zp (Website cvent.com). Eine Best\u00e4tigung wird per E-Mail versandt (Absender der Best\u00e4tigungs-E-Mail ist grenzach.events at roche.com).\n\nDie \u00dcbertragung findet virtuell mit ZOOM statt. Nur die Referent:innen und der Moderator werden mit einem Videobild \u00fcbertragen. Fragen werden per Chatfunktion (F/A) mit dem Webconferencing-Tool Zoom gestellt.",
        "reactions_count": 80,
        "comments_count": null,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "2w",
        "description": "\ud83c\udfe5 ML Engineer Opportunity: Build AI Infrastructure for European Healthcare \ud83c\udfe5\n\nWe're looking for an ML Engineer based in Germany to join our international team at aiomics. If you know someone great\u2014or if this sounds like you\u2014please reach out directly. \ud83d\ude4b\u2642\ufe0f \n\nWhat we're building: We're currently implementing our AI platform across 7 hospital facilities with advanced medical services. Our product is designed to save medical teams hours daily on documentation, using that time for meaningful patient care instead while having much better information on their patients. Our early hospital partners alone could reach 5M patients annually\u2014and we are only getting started. There have several more implementations in preparation right now.\n\nWhat we're working on: \n\u2022 Building ML systems that process unstructured medical data in various languages\u2014from handwritten notes to discharge letters to lab reports \n\u2022 Developing intelligent document extraction and structuring with ICD-10/SNOMED CT coding \n\u2022 Creating AI assistants that help draft all sorts of medical documentation, patient education material, and insurance and compliance forms \n\u2022 Designing for real-world healthcare: multilingual processing (24+ languages), GDPR/MDR compliance built in \n\u2022 Working on challenging NLP problems specific to European medical language patterns\n\nYou'll work directly with our CTO Nikita Tarasov on core infrastructure decisions and implement the latest ML technologies in a compliant manner. No competing projects\u2014just one product, built right.\n\nOur team: 5 core members from different countries, speaking 9 languages collectively. I'm a doctor-turned-founder, bringing healthcare expertise to technical decisions. We reason from first principles, move fast, remove roadblocks efficiently, and build solid foundations\u2014no shortcuts on quality.\n\nRequirements: \n\u2022 Work authorization in Germany \n\u2022 Drive to transform healthcare through technology\n\u2022 German language skills valuable (other European languages also great) \n\nWe prefer warm introductions\u2014no recruiters please. Join us in giving healthcare professionals their time back and enabling them to do what made them choose this profession in the first place: being there for their patients.\n\n#MachineLearning #HealthTech #MLJobs #GermanyJobs #AIEngineering",
        "reactions_count": 62,
        "comments_count": 6,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 175,
        "date": "3w",
        "description": "\ud83d\ude80 Remote Access Tools Market Industry\u00a02025\n\n\ud83d\udce5 \ud835\udc00\ud835\udc1c\ud835\udc1c\ud835\udc1e\ud835\udc2c\ud835\udc2c \ud835\udc0f\ud835\udc2b\ud835\udc1e\ud835\udc26\ud835\udc22\ud835\udc2e\ud835\udc26 \ud835\udc11\ud835\udc1e\ud835\udc29\ud835\udc28\ud835\udc2b\ud835\udc2d:\u00a0https://lnkd.in/eE-xuhmz\n\u00a0\nThe Remote Access Tools Market Industry is on the brink of a transformative shift, driven by innovation, evolving consumer demand, and cutting-edge advancements. As we step into 2025, businesses must stay ahead with data-driven insights to capture emerging opportunities. This is more than just a report\u2014it\u2019s a roadmap for success in 2025 and beyond. Whether you're an investor, business leader, or industry enthusiast, staying informed is the key to a competitive edge.\n\u00a0\n\ud835\udc0a\ud835\udc1e\ud835\udc32-\ud835\udc29\ud835\udc25\ud835\udc1a\ud835\udc32\ud835\udc1e\ud835\udc2b\ud835\udc2c : \n\nSynapse Product Development\u00a0\u00a0\nDigitalituM\u00a0\u00a0\nWikifactory\u00a0\u00a0\nIP Access International\u00a0\u00a0\nNoralis\u00a0\u00a0\nUnisync Group Limited, Inc.\u00a0\u00a0\nBlastWave\u00a0\u00a0\nCarbon Oral Health Applications\u00a0\u00a0\nLearning A-Z Lions\u00a0\u00a0\nC Prompt Solutions Pvt. Ltd.\u00a0\u00a0\nJM Origin\u00a0\u00a0\nTelebionix\u00a0\u00a0\nDeep Block\u00a0\u00a0\nEcount ERP\u00a0\u00a0\nCaldwell Electrical Contractors\u00a0\u00a0\nIngetrol\u00a0\u00a0\nMayfield Exploration and Production Services Limited\u00a0\u00a0\nLatitude Technologies\u00a0\u00a0\nHoover Pumping Systems\u00a0\u00a0\nPipe Vision Inspection | PVI\u00a0\u00a0\nEpoptia Cloud MES\u00a0\u00a0\nBravo Solar Energy Saudi Arabia\u00a0\u00a0\nTCIC, INC.\u00a0\u00a0\nSparks Instruments\u00a0\u00a0\ntibbo\u00a0\nDDS Company\u00a0\u00a0\nBuilding Ontario Fund Bloc Systems\u00a0\u00a0\nJobs In New Zealand And Australia Listings\u00a0\u00a0\nRaagz IT Solutions\u00a0\u00a0\nTechcare LLC (formerly Graphtech Systems)\u00a0\u00a0\nCalterion\naiomics\u00a0\u00a0\nReonix Automation Inc.\u00a0\u00a0\nMSB Accounting Solutions LLC\u00a0\u00a0\nRAPID UAV Services & Environmental Engineering Consultant\u00a0\u00a0\nNxtLevel\nPU Consulting AB | Consulting, Distribution & New Development\u00a0\u00a0\nSysgem\nSedia Biosciences Corp. (India)\u00a0\u00a0\nControl Logics\n\n\ud83d\udccc \ud835\udc0a\ud835\udc1e\ud835\udc32 \ud835\udc07\ud835\udc22\ud835\udc20\ud835\udc21\ud835\udc25\ud835\udc22\ud835\udc20\ud835\udc21\ud835\udc2d\ud835\udc2c:\n\u2705 \ud835\udc0c\ud835\udc1a\ud835\udc2b\ud835\udc24\ud835\udc1e\ud835\udc2d \ud835\udc20\ud835\udc2b\ud835\udc28\ud835\udc30\ud835\udc2d\ud835\udc21 \ud835\udc29\ud835\udc2b\ud835\udc28\ud835\udc23\ud835\udc1e\ud835\udc1c\ud835\udc2d\ud835\udc22\ud835\udc28\ud835\udc27\ud835\udc2c & \ud835\udc2d\ud835\udc2b\ud835\udc1e\ud835\udc27\ud835\udc1d\ud835\udc2c \ud83d\udcc8\n\u2705 \ud835\udc11\ud835\udc1e\ud835\udc20\ud835\udc22\ud835\udc28\ud835\udc27\ud835\udc1a\ud835\udc25 & \ud835\udc2c\ud835\udc1e\ud835\udc1c\ud835\udc2d\ud835\udc28\ud835\udc2b\ud835\udc1a\ud835\udc25 \ud835\udc22\ud835\udc27\ud835\udc2c\ud835\udc22\ud835\udc20\ud835\udc21\ud835\udc2d\ud835\udc2c \ud83c\udf0e\n\u2705 \ud835\udc02\ud835\udc28\ud835\udc26\ud835\udc29\ud835\udc1e\ud835\udc2d\ud835\udc22\ud835\udc2d\ud835\udc22\ud835\udc2f\ud835\udc1e \ud835\udc25\ud835\udc1a\ud835\udc27\ud835\udc1d\ud835\udc2c\ud835\udc1c\ud835\udc1a\ud835\udc29\ud835\udc1e & \ud835\udc24\ud835\udc1e\ud835\udc32 \ud835\udc29\ud835\udc25\ud835\udc1a\ud835\udc32\ud835\udc1e\ud835\udc2b\ud835\udc2c \ud83c\udfc6\n\u2705 \ud835\udc05\ud835\udc2e\ud835\udc2d\ud835\udc2e\ud835\udc2b\ud835\udc1e \ud835\udc28\ud835\udc29\ud835\udc29\ud835\udc28\ud835\udc2b\ud835\udc2d\ud835\udc2e\ud835\udc27\ud835\udc22\ud835\udc2d\ud835\udc22\ud835\udc1e\ud835\udc2c & \ud835\udc1c\ud835\udc21\ud835\udc1a\ud835\udc25\ud835\udc25\ud835\udc1e\ud835\udc27\ud835\udc20\ud835\udc1e\ud835\udc2c \ud83d\udd0d\n\u00a0\n#RemoteAccessTools #RemoteAccessToolsMarket #MarketTrends #BusinessGrowth #IndustryInsights #MarketResearch #Innovation #Management #DigitalMarketing #Technology #Creativity #Futurism #Startups #Marketing #SocialMedia #SocialNetworking",
        "reactions_count": 4,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 103,
        "date": "4w",
        "description": "Two startup reality checks from our journey:\nFirst: Everyone talks about building solutions with end users, but in healthcare, getting genuine access to clinical teams who can dedicate time to co-creation is incredibly challenging.\n\nSecond: German hospitals have a reputation for being slow to adopt new technologies. Just a few months ago, we couldn't have imagined we'd be spending most of our time building directly with hospital teams.\n\nBut something has shifted. Healthcare organizations are now actively seeking innovation partners, and MEDICLIN under Dr. Christian Dohmen-Griesenbach's leadership is pioneering this change.\n\nWhat makes this partnership remarkable is the depth of collaboration. Linda Pistor, Dr. Dimitrios Artemis, Prof. Dr. Philipp H\u00fcllemann, Dr. Max Holger Warnke, Dr. Florian Weber, and their colleagues aren't just stakeholders providing occasional feedback. They're opening up their workflows, sharing their daily  challenges with documentation, and actively shaping how our infrastructure evolves.\n\nWe're learning from the field what rehabilitation physicians need during admissions, how nurses navigate between systems, what information therapists actually need for treatment planning, and what legally mandated compliance tasks are keeping staff away from meaningful patient interactions. This isn't theoretical user research \u2013 it's building alongside the people who know exactly where technology can make the biggest difference.\n\nThe readiness for change we're witnessing at MEDICLIN signals something bigger: German healthcare is ready to pick up significant pace in digital transformation.\n\nMore insights from this collaboration coming soon.\n\n#StartupLessons #HealthTech #GermanHealthcare #DigitalTransformation",
        "reactions_count": 1,
        "comments_count": 2,
        "reshared_post_author": "Dr. Christian Dohmen-Griesenbach",
        "reshared_post_author_url": "https://de.linkedin.com/in/dr-christian-dohmen-griesenbach-3057a815b",
        "reshared_post_author_headline": "Leiter KI und Digitale Transformation bei der MEDICLIN Management GmbH & Co. KG | Ideentreiber f\u00fcr die Zukunft des Gesundheitswesens",
        "reshared_post_description": "\ud83d\udca1 Pfingsten, Heiliger Geist und die digitale Erleuchtung im Gesundheitswesen\n\nPfingsten steht traditionell f\u00fcr Inspiration, Aufbruch \u2013 und den \u201eHeiligen Geist\u201c als Impulsgeber f\u00fcr Verst\u00e4ndigung und Ver\u00e4nderung. Ein passender Anlass, um \u00fcber strukturelle Erneuerung im Gesundheitswesen nachzudenken.\n\n\ud83e\udde0 Der aktuelle Interview-Beitrag mit dem Arzt und KI-Experten Dr. Sven Jungmann im FOCUS zur Rolle von KI in der Medizin bringt zentrale Gedanken auf den Punkt:\n\n\u2022 KI ist kein Ersatz, sondern ein Werkzeug, um \u00e4rztliches Denken zu erweitern.\n\u2022 Der Einstieg gelingt \u00fcber pragmatische Automatisierungen \u2013 etwa in der Dokumentation und Prozessstruktur.\n\u2022 Die Grundlage bleibt: saubere, vielf\u00e4ltige und vernetzte Daten.\n\nhttps://lnkd.in/ehksfPtC\n\n\ud83d\udee0\ufe0f Genau hier setzen wir auch bei #MEDICLIN gemeinsam mit Sven in einem zentralen Projekt an. Dort befassen wir uns mit der automatisierten Strukturierung gro\u00dfer Mengen klinischer Informationen \u2013 aus Vorsystemen, von Papier und aus unstrukturierten Formaten. Ziel ist es, diese Daten f\u00fcr eine intelligente Weiterverarbeitung verf\u00fcgbar zu machen: schneller, nachvollziehbarer, nutzbar f\u00fcr Patientenversorgung und Entscheidungsunterst\u00fctzung und Entlastung. Und nat\u00fcrlich folgt dieses Projekt einer Gesamtstrategie.\n\n\ud83e\udd1d Besonders wichtig:\nDieses Projekt entsteht nicht top-down, sondern wird aus der klinischen Praxis heraus gestaltet \u2013 gemeinsam mit \u00c4rzten, Therapeuten, Pflegekr\u00e4ften, Qualit\u00e4tsmanagern und Kaufleuten. Die digitale Transformation wird dadurch konkreter, anschlussf\u00e4higer und nachhaltiger. Deshalb ein gro\u00dfer Dank an Linda Pistor, Dr. Dimitrios Artemis, Prof. Dr. Philipp H\u00fcllemann, Dr. Max Holger Warnke, Dr. Florian Weber u.v.m. \u00fcber den Blick hinter die Kulissen der Reha von heute. Wer sich noch am Projekt beteiligen m\u00f6chte, kann sich gerne bei mir melden!\n\n\ud83c\udf2c\ufe0f Pfingsten als Fest der Verst\u00e4ndigung erinnert uns daran, dass Fortschritt dort gelingt, wo wir Komplexit\u00e4t in Struktur \u00fcberf\u00fchren \u2013 mit digitalen Mitteln, aber im Dienst eines menschlichen Gesundheitswesens.\n\n#DigitaleGesundheit #KIinderReha #BottomUpInnovation #Pfingsten2025",
        "reshared_post_date": "4w",
        "reshared_post_followers": null
      },
      {
        "followers": 103,
        "date": "2mo",
        "description": "Milestone Achievement: Aiomics\u00ae Recognized by BAFA INVEST Zuschuss Program\nWe're pleased to share that we have been approved for the BAFA INVEST Zuschuss program by the German Federal Office for Economic Affairs and Export Control (BAFA). This recognition formally classifies us as a \"young innovative company\" within the German startup ecosystem.\n\nWhat is the BAFA INVEST Zuschuss?\nFor those unfamiliar with this program, it represents a strategic initiative by the German government to stimulate investment in innovative early-stage companies. The program functions as a de facto government endorsement of a startup's innovation potential and business model viability.\n\nThe Significance Beyond Financial Benefits\nThis approval process involves an independent evaluation of our company conducted by federal authorities.\n\nThis designation carries three key implications:\n\n1. External Validation: It provides independent verification of our innovation claims and business model from government experts who evaluate hundreds of companies annually.\n2. Risk Mitigation for Investors: The program offers private investors a 15% reimbursement on their investment and a 25% reimbursement on their exit sum, effectively improving the risk-return profile of investing in our company.\n3. Ecosystem Recognition: It positions us within Germany's formal innovation framework, potentially opening doors to additional innovation-focused resources, partnerships, and networks.\n\nWe see this milestone not merely as a financial incentive mechanism, but as validation of our team's hard work and our strategic direction. And we're pleased to be able to sweeten the deal for our ever so supportive investors, many of which have been an integral part of Dr. Sven Jungmann's previous journey(s). \n\nWe're grateful for this recognition and look forward to delivering on the innovative potential that this designation acknowledges.\n\n#Innovation #StartupGrowth #GermanTech #BAFA #aiomics",
        "reactions_count": 39,
        "comments_count": 2,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "2mo",
        "description": "In drei Wochen ist es endlich so weit Dr. Tina Wenz Philipp Koch Dr. Sven Jungmann Jeremy D\u00e4hn Charlene Nowotny Nico Vogler Daniel Dominik Hecht Seroton Minddistrict DACH POLYPOINT Deutschland GmbH Healex DMI GmbH & Co. KG u.v.a.m. \ud83d\ude80\ud83d\ude80\ud83e\udd16\ud83e\udd16\ud83d\ude0e\ud83d\ude0e Freu mich drauf! Schon jetzt ein Spoiler: Wir werden definitiv mehr an den Potenzialen arbeiten als an Risiken, denn Bremser und Bedenkentr\u00e4ger gibt\u2018s hierzulande schon zu gen\u00fcge \ud83d\ude09",
        "reactions_count": 37,
        "comments_count": 9,
        "reshared_post_author": "Deutsches Psychiatrieforum e.V.",
        "reshared_post_author_url": "https://de.linkedin.com/company/deutsches-psychiatrieforum-e-v",
        "reshared_post_author_headline": null,
        "reshared_post_description": "\ud83d\udce3 Innovative Ans\u00e4tze und Expertenwissen: Seien Sie dabei! \nWir laden Sie herzlich zu unseren inspirierenden Workshops im Rahmen der Fachtagung am Donnerstagnachmittag ein. Diese Veranstaltung bietet Ihnen die perfekte Plattform, um Ihr Wissen zu erweitern und sich mit Gleichgesinnten auszutauschen.\n\n\ud83d\udd0d Was erwartet Sie?\nHochkar\u00e4tige Referenten:\u00a0Profitieren Sie von den Erfahrungen und dem Wissen f\u00fchrender Experten im Bereich Psychiatrie.\nInteraktive Sessions:\u00a0Tauchen Sie ein in praxisnahe Workshops, die Ihnen sofort umsetzbare Strategien und neueste Forschungsergebnisse bieten.\nNetzwerk-M\u00f6glichkeiten:\u00a0Nutzen Sie die Chance, wertvolle Kontakte zu kn\u00fcpfen und Ihr berufliches Netzwerk zu erweitern.\n\n\ud83c\udfaf Sichern Sie sich Ihren Platz! Der Link zum detaillierten Programm und zur Anmeldung finden Sie in den Kommentaren. Wir freuen uns darauf, Sie bei unseren Workshops begr\u00fc\u00dfen zu d\u00fcrfen und gemeinsam neue Horizonte zu erkunden.\n\n#Psychiatrie #Fachtagung #Workshops #Weiterbildung #Netzwerken #Innovation",
        "reshared_post_date": "2mo",
        "reshared_post_followers": null
      },
      {
        "followers": 3594,
        "date": "2mo",
        "description": "\ud83d\udea8 \ud835\udde0\ud835\uddfc\ud835\uddff\ud835\uddfd\ud835\uddf5\ud835\udde5\ud835\uddee\ud835\uddf1\ud835\uddee\ud835\uddff \u2013 \ud835\udde7\ud835\uddfc\ud835\uddfd \ud835\udfef \ud835\udde6\ud835\ude01\ud835\uddee\ud835\uddff\ud835\ude01\ud835\ude02\ud835\uddfd\ud835\ude00 \ud835\uddfc\ud835\uddf3 \ud835\ude01\ud835\uddf5\ud835\uddf2 \ud835\uddea\ud835\uddf2\ud835\uddf2\ud835\uddf8 \ud83d\udea8 \n\nWe hope your portfolio is doing fine. \ud83d\udc40\n\nSeriously:\u00a0While the market currently feels like an on/off situationship,\u00a0there is at least one constant you can count on in your life \u2013\u00a0the weekly\u00a0\ud835\udde0\ud835\uddfc\ud835\uddfb\ud835\uddf1\ud835\uddee\ud835\ude06 \ud835\udde0\ud835\uddfc\ud835\uddff\ud835\uddfd\ud835\uddf5\ud835\uddee\ud835\uddf6\ud835\ude00 \ud835\udde3\ud835\uddfc\ud835\ude00\ud835\ude01.\u00a0\ud83d\ude0e\n\nThis week, we have uploaded\u00a0\ud835\udfee\ud835\udfed\ud835\udfef \ud835\uddfb\ud835\uddf2\ud835\ude04 \ud835\uddf1\ud835\uddf2\ud835\uddee\ud835\uddf9\ud835\ude00\u00a0(including\u00a0\ud835\udff0\ud835\udfef \ud835\ude00\ud835\ude01\ud835\uddf2\ud835\uddee\ud835\uddf9\ud835\ude01\ud835\uddf5 \ud835\uddf3\ud835\uddfc\ud835\ude02\ud835\uddfb\ud835\uddf1\ud835\uddf2\ud835\uddff\ud835\ude00) from\u00a0\ud835\udfed\ud835\udff4 \ud835\uddf0\ud835\uddfc\ud835\ude02\ud835\uddfb\ud835\ude01\ud835\uddff\ud835\uddf6\ud835\uddf2\ud835\ude00\u00a0to our platform,\u00a0with a focus on some really\u00a0\ud835\ude00\ud835\uddfa\ud835\uddee\ud835\uddff\ud835\ude01 \ud835\udde3\ud835\uddf5\ud835\uddd7 \ud835\uddf3\ud835\uddfc\ud835\ude02\ud835\uddfb\ud835\uddf1\ud835\uddf2\ud835\uddff\ud835\ude00\u00a0from\u00a0the BioTech and MedTech space. \ud83d\udc68\ud83c\udffb\ud83d\udd2c\ud83e\uddec\n\nSee our\u00a0\ud835\udde7\ud835\uddfc\ud835\uddfd \ud835\udfef \ud835\uddd7\ud835\uddf2\ud835\uddee\ud835\uddf9\ud835\ude00\u00a0of the week down below! \u2b07\ufe0f\n\n---\n\n(1) \ud83c\udde9\ud83c\uddea aiomics (Dr. Sven Jungmann, Nikita Tarasov & Karim Galzahr)\n(2) \ud83c\uddec\ud83c\udde7 Aethox Therapeutics (Charles Spicer, James Arnold & Khondaker Miraz Rahman)\n(3) \ud83c\udde9\ud83c\uddea Stealth Founder: Christoph Sch\u00fctte\n\nGet \ud835\udfee\ud835\udfec\ud835\udfec+ \ud835\uddf1\ud835\uddf2\ud835\uddee\ud835\uddf9\ud835\ude00\u00a0on a weekly basis - get started with our newsletter and our Free Demo today. Links are in the comments! \u2b07\ufe0f",
        "reactions_count": 15,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 61,
        "date": "1mo",
        "description": "Milestone Achievement: Aiomics\u00ae Recognized by BAFA INVEST Zuschuss Program\nWe're pleased to share that we have been approved for the BAFA INVEST Zuschuss program by the German Federal Office for Economic Affairs and Export Control (BAFA). This recognition formally classifies us as a \"young innovative company\" within the German startup ecosystem.\n\nWhat is the BAFA INVEST Zuschuss?\nFor those unfamiliar with this program, it represents a strategic initiative by the German government to stimulate investment in innovative early-stage companies. The program functions as a de facto government endorsement of a startup's innovation potential and business model viability.\n\nThe Significance Beyond Financial Benefits\nThis approval process involves an independent evaluation of our company conducted by federal authorities.\n\nThis designation carries three key implications:\n\n1. External Validation: It provides independent verification of our innovation claims and business model from government experts who evaluate hundreds of companies annually.\n2. Risk Mitigation for Investors: The program offers private investors a 15% reimbursement on their investment and a 25% reimbursement on their exit sum, effectively improving the risk-return profile of investing in our company.\n3. Ecosystem Recognition: It positions us within Germany's formal innovation framework, potentially opening doors to additional innovation-focused resources, partnerships, and networks.\n\nWe see this milestone not merely as a financial incentive mechanism, but as validation of our team's hard work and our strategic direction. And we're pleased to be able to sweeten the deal for our ever so supportive investors, many of which have been an integral part of Dr. Sven Jungmann's previous journey(s). \n\nWe're grateful for this recognition and look forward to delivering on the innovative potential that this designation acknowledges.\n\n#Innovation #StartupGrowth #GermanTech #BAFA #aiomics",
        "reactions_count": 39,
        "comments_count": 2,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "1mo",
        "description": "In drei Wochen ist es endlich so weit Dr. Tina Wenz Philipp Koch Dr. Sven Jungmann Jeremy D\u00e4hn Charlene Nowotny Nico Vogler Daniel Dominik Hecht Seroton Minddistrict DACH POLYPOINT Deutschland GmbH Healex DMI GmbH & Co. KG u.v.a.m. \ud83d\ude80\ud83d\ude80\ud83e\udd16\ud83e\udd16\ud83d\ude0e\ud83d\ude0e Freu mich drauf! Schon jetzt ein Spoiler: Wir werden definitiv mehr an den Potenzialen arbeiten als an Risiken, denn Bremser und Bedenkentr\u00e4ger gibt\u2018s hierzulande schon zu gen\u00fcge \ud83d\ude09",
        "reactions_count": 37,
        "comments_count": 9,
        "reshared_post_author": "Deutsches Psychiatrieforum e.V.",
        "reshared_post_author_url": "https://de.linkedin.com/company/deutsches-psychiatrieforum-e-v",
        "reshared_post_author_headline": null,
        "reshared_post_description": "\ud83d\udce3 Innovative Ans\u00e4tze und Expertenwissen: Seien Sie dabei! \nWir laden Sie herzlich zu unseren inspirierenden Workshops im Rahmen der Fachtagung am Donnerstagnachmittag ein. Diese Veranstaltung bietet Ihnen die perfekte Plattform, um Ihr Wissen zu erweitern und sich mit Gleichgesinnten auszutauschen.\n\n\ud83d\udd0d Was erwartet Sie?\nHochkar\u00e4tige Referenten:\u00a0Profitieren Sie von den Erfahrungen und dem Wissen f\u00fchrender Experten im Bereich Psychiatrie.\nInteraktive Sessions:\u00a0Tauchen Sie ein in praxisnahe Workshops, die Ihnen sofort umsetzbare Strategien und neueste Forschungsergebnisse bieten.\nNetzwerk-M\u00f6glichkeiten:\u00a0Nutzen Sie die Chance, wertvolle Kontakte zu kn\u00fcpfen und Ihr berufliches Netzwerk zu erweitern.\n\n\ud83c\udfaf Sichern Sie sich Ihren Platz! Der Link zum detaillierten Programm und zur Anmeldung finden Sie in den Kommentaren. Wir freuen uns darauf, Sie bei unseren Workshops begr\u00fc\u00dfen zu d\u00fcrfen und gemeinsam neue Horizonte zu erkunden.\n\n#Psychiatrie #Fachtagung #Workshops #Weiterbildung #Netzwerken #Innovation",
        "reshared_post_date": "1mo",
        "reshared_post_followers": null
      },
      {
        "followers": 3545,
        "date": "1mo",
        "description": "\ud83d\udea8 \ud835\udde0\ud835\uddfc\ud835\uddff\ud835\uddfd\ud835\uddf5\ud835\udde5\ud835\uddee\ud835\uddf1\ud835\uddee\ud835\uddff \u2013 \ud835\udde7\ud835\uddfc\ud835\uddfd \ud835\udfef \ud835\udde6\ud835\ude01\ud835\uddee\ud835\uddff\ud835\ude01\ud835\ude02\ud835\uddfd\ud835\ude00 \ud835\uddfc\ud835\uddf3 \ud835\ude01\ud835\uddf5\ud835\uddf2 \ud835\uddea\ud835\uddf2\ud835\uddf2\ud835\uddf8 \ud83d\udea8 \n\nWe hope your portfolio is doing fine. \ud83d\udc40\n\nSeriously:\u00a0While the market currently feels like an on/off situationship,\u00a0there is at least one constant you can count on in your life \u2013\u00a0the weekly\u00a0\ud835\udde0\ud835\uddfc\ud835\uddfb\ud835\uddf1\ud835\uddee\ud835\ude06 \ud835\udde0\ud835\uddfc\ud835\uddff\ud835\uddfd\ud835\uddf5\ud835\uddee\ud835\uddf6\ud835\ude00 \ud835\udde3\ud835\uddfc\ud835\ude00\ud835\ude01.\u00a0\ud83d\ude0e\n\nThis week, we have uploaded\u00a0\ud835\udfee\ud835\udfed\ud835\udfef \ud835\uddfb\ud835\uddf2\ud835\ude04 \ud835\uddf1\ud835\uddf2\ud835\uddee\ud835\uddf9\ud835\ude00\u00a0(including\u00a0\ud835\udff0\ud835\udfef \ud835\ude00\ud835\ude01\ud835\uddf2\ud835\uddee\ud835\uddf9\ud835\ude01\ud835\uddf5 \ud835\uddf3\ud835\uddfc\ud835\ude02\ud835\uddfb\ud835\uddf1\ud835\uddf2\ud835\uddff\ud835\ude00) from\u00a0\ud835\udfed\ud835\udff4 \ud835\uddf0\ud835\uddfc\ud835\ude02\ud835\uddfb\ud835\ude01\ud835\uddff\ud835\uddf6\ud835\uddf2\ud835\ude00\u00a0to our platform,\u00a0with a focus on some really\u00a0\ud835\ude00\ud835\uddfa\ud835\uddee\ud835\uddff\ud835\ude01 \ud835\udde3\ud835\uddf5\ud835\uddd7 \ud835\uddf3\ud835\uddfc\ud835\ude02\ud835\uddfb\ud835\uddf1\ud835\uddf2\ud835\uddff\ud835\ude00\u00a0from\u00a0the BioTech and MedTech space. \ud83d\udc68\ud83c\udffb\ud83d\udd2c\ud83e\uddec\n\nSee our\u00a0\ud835\udde7\ud835\uddfc\ud835\uddfd \ud835\udfef \ud835\uddd7\ud835\uddf2\ud835\uddee\ud835\uddf9\ud835\ude00\u00a0of the week down below! \u2b07\ufe0f\n\n---\n\n(1) \ud83c\udde9\ud83c\uddea aiomics (Dr. Sven Jungmann, Nikita Tarasov & Karim Galzahr)\n(2) \ud83c\uddec\ud83c\udde7 Aethox Therapeutics (Charles Spicer, James Arnold & Khondaker Miraz Rahman)\n(3) \ud83c\udde9\ud83c\uddea Stealth Founder: Christoph Sch\u00fctte\n\nGet \ud835\udfee\ud835\udfec\ud835\udfec+ \ud835\uddf1\ud835\uddf2\ud835\uddee\ud835\uddf9\ud835\ude00\u00a0on a weekly basis - get started with our newsletter and our Free Demo today. Links are in the comments! \u2b07\ufe0f",
        "reactions_count": 13,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 48,
        "date": "2d",
        "description": "Milestone Achievement: Aiomics\u00ae Recognized by BAFA INVEST Zuschuss Program\nWe're pleased to share that we have been approved for the BAFA INVEST Zuschuss program by the German Federal Office for Economic Affairs and Export Control (BAFA). This recognition formally classifies us as a \"young innovative company\" within the German startup ecosystem.\n\nWhat is the BAFA INVEST Zuschuss?\nFor those unfamiliar with this program, it represents a strategic initiative by the German government to stimulate investment in innovative early-stage companies. The program functions as a de facto government endorsement of a startup's innovation potential and business model viability.\n\nThe Significance Beyond Financial Benefits\nThis approval process involves an independent evaluation of our company conducted by federal authorities.\n\nThis designation carries three key implications:\n\n1. External Validation: It provides independent verification of our innovation claims and business model from government experts who evaluate hundreds of companies annually.\n2. Risk Mitigation for Investors: The program offers private investors a 15% reimbursement on their investment and a 25% reimbursement on their exit sum, effectively improving the risk-return profile of investing in our company.\n3. Ecosystem Recognition: It positions us within Germany's formal innovation framework, potentially opening doors to additional innovation-focused resources, partnerships, and networks.\n\nWe see this milestone not merely as a financial incentive mechanism, but as validation of our team's hard work and our strategic direction. And we're pleased to be able to sweeten the deal for our ever so supportive investors, many of which have been an integral part of Dr. Sven Jungmann's previous journey(s). \n\nWe're grateful for this recognition and look forward to delivering on the innovative potential that this designation acknowledges.\n\n#Innovation #StartupGrowth #GermanTech #BAFA #aiomics",
        "reactions_count": 34,
        "comments_count": 2,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": null,
        "date": "1w",
        "description": "In drei Wochen ist es endlich so weit Dr. Tina Wenz Philipp Koch Dr. Sven Jungmann Jeremy D\u00e4hn Charlene Nowotny Nico Vogler Daniel Dominik Hecht Seroton Minddistrict DACH POLYPOINT Deutschland GmbH Healex DMI GmbH & Co. KG u.v.a.m. \ud83d\ude80\ud83d\ude80\ud83e\udd16\ud83e\udd16\ud83d\ude0e\ud83d\ude0e Freu mich drauf! Schon jetzt ein Spoiler: Wir werden definitiv mehr an den Potenzialen arbeiten als an Risiken, denn Bremser und Bedenkentr\u00e4ger gibt\u2018s hierzulande schon zu gen\u00fcge \ud83d\ude09",
        "reactions_count": 33,
        "comments_count": 9,
        "reshared_post_author": "Deutsches Psychiatrieforum e.V.",
        "reshared_post_author_url": "https://de.linkedin.com/company/deutsches-psychiatrieforum-e-v",
        "reshared_post_author_headline": null,
        "reshared_post_description": "\ud83d\udce3 Innovative Ans\u00e4tze und Expertenwissen: Seien Sie dabei! \nWir laden Sie herzlich zu unseren inspirierenden Workshops im Rahmen der Fachtagung am Donnerstagnachmittag ein. Diese Veranstaltung bietet Ihnen die perfekte Plattform, um Ihr Wissen zu erweitern und sich mit Gleichgesinnten auszutauschen.\n\n\ud83d\udd0d Was erwartet Sie?\nHochkar\u00e4tige Referenten:\u00a0Profitieren Sie von den Erfahrungen und dem Wissen f\u00fchrender Experten im Bereich Psychiatrie.\nInteraktive Sessions:\u00a0Tauchen Sie ein in praxisnahe Workshops, die Ihnen sofort umsetzbare Strategien und neueste Forschungsergebnisse bieten.\nNetzwerk-M\u00f6glichkeiten:\u00a0Nutzen Sie die Chance, wertvolle Kontakte zu kn\u00fcpfen und Ihr berufliches Netzwerk zu erweitern.\n\n\ud83c\udfaf Sichern Sie sich Ihren Platz! Der Link zum detaillierten Programm und zur Anmeldung finden Sie in den Kommentaren. Wir freuen uns darauf, Sie bei unseren Workshops begr\u00fc\u00dfen zu d\u00fcrfen und gemeinsam neue Horizonte zu erkunden.\n\n#Psychiatrie #Fachtagung #Workshops #Weiterbildung #Netzwerken #Innovation",
        "reshared_post_date": "3w",
        "reshared_post_followers": null
      },
      {
        "followers": 3501,
        "date": "3w",
        "description": "\ud83d\udea8 \ud835\udde0\ud835\uddfc\ud835\uddff\ud835\uddfd\ud835\uddf5\ud835\udde5\ud835\uddee\ud835\uddf1\ud835\uddee\ud835\uddff \u2013 \ud835\udde7\ud835\uddfc\ud835\uddfd \ud835\udfef \ud835\udde6\ud835\ude01\ud835\uddee\ud835\uddff\ud835\ude01\ud835\ude02\ud835\uddfd\ud835\ude00 \ud835\uddfc\ud835\uddf3 \ud835\ude01\ud835\uddf5\ud835\uddf2 \ud835\uddea\ud835\uddf2\ud835\uddf2\ud835\uddf8 \ud83d\udea8 \n\nWe hope your portfolio is doing fine. \ud83d\udc40\n\nSeriously:\u00a0While the market currently feels like an on/off situationship,\u00a0there is at least one constant you can count on in your life \u2013\u00a0the weekly\u00a0\ud835\udde0\ud835\uddfc\ud835\uddfb\ud835\uddf1\ud835\uddee\ud835\ude06 \ud835\udde0\ud835\uddfc\ud835\uddff\ud835\uddfd\ud835\uddf5\ud835\uddee\ud835\uddf6\ud835\ude00 \ud835\udde3\ud835\uddfc\ud835\ude00\ud835\ude01.\u00a0\ud83d\ude0e\n\nThis week, we have uploaded\u00a0\ud835\udfee\ud835\udfed\ud835\udfef \ud835\uddfb\ud835\uddf2\ud835\ude04 \ud835\uddf1\ud835\uddf2\ud835\uddee\ud835\uddf9\ud835\ude00\u00a0(including\u00a0\ud835\udff0\ud835\udfef \ud835\ude00\ud835\ude01\ud835\uddf2\ud835\uddee\ud835\uddf9\ud835\ude01\ud835\uddf5 \ud835\uddf3\ud835\uddfc\ud835\ude02\ud835\uddfb\ud835\uddf1\ud835\uddf2\ud835\uddff\ud835\ude00) from\u00a0\ud835\udfed\ud835\udff4 \ud835\uddf0\ud835\uddfc\ud835\ude02\ud835\uddfb\ud835\ude01\ud835\uddff\ud835\uddf6\ud835\uddf2\ud835\ude00\u00a0to our platform,\u00a0with a focus on some really\u00a0\ud835\ude00\ud835\uddfa\ud835\uddee\ud835\uddff\ud835\ude01 \ud835\udde3\ud835\uddf5\ud835\uddd7 \ud835\uddf3\ud835\uddfc\ud835\ude02\ud835\uddfb\ud835\uddf1\ud835\uddf2\ud835\uddff\ud835\ude00\u00a0from\u00a0the BioTech and MedTech space. \ud83d\udc68\ud83c\udffb\ud83d\udd2c\ud83e\uddec\n\nSee our\u00a0\ud835\udde7\ud835\uddfc\ud835\uddfd \ud835\udfef \ud835\uddd7\ud835\uddf2\ud835\uddee\ud835\uddf9\ud835\ude00\u00a0of the week down below! \u2b07\ufe0f\n\n---\n\n(1) \ud83c\udde9\ud83c\uddea aiomics (Dr. Sven Jungmann, Nikita Tarasov & Karim Galzahr)\n(2) \ud83c\uddec\ud83c\udde7 Aethox Therapeutics (Charles Spicer, James Arnold & Khondaker Miraz Rahman)\n(3) \ud83c\udde9\ud83c\uddea Stealth Founder: Christoph Sch\u00fctte\n\nGet \ud835\udfee\ud835\udfec\ud835\udfec+ \ud835\uddf1\ud835\uddf2\ud835\uddee\ud835\uddf9\ud835\ude00\u00a0on a weekly basis - get started with our newsletter and our Free Demo today. Links are in the comments! \u2b07\ufe0f",
        "reactions_count": 14,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 3479,
        "date": "1w",
        "description": "\ud83d\udea8 \ud835\udde0\ud835\uddfc\ud835\uddff\ud835\uddfd\ud835\uddf5\ud835\udde5\ud835\uddee\ud835\uddf1\ud835\uddee\ud835\uddff \u2013 \ud835\udde7\ud835\uddfc\ud835\uddfd \ud835\udfef \ud835\udde6\ud835\ude01\ud835\uddee\ud835\uddff\ud835\ude01\ud835\ude02\ud835\uddfd\ud835\ude00 \ud835\uddfc\ud835\uddf3 \ud835\ude01\ud835\uddf5\ud835\uddf2 \ud835\uddea\ud835\uddf2\ud835\uddf2\ud835\uddf8 \ud83d\udea8 \n\nWe hope your portfolio is doing fine. \ud83d\udc40\n\nSeriously:\u00a0While the market currently feels like an on/off situationship,\u00a0there is at least one constant you can count on in your life \u2013\u00a0the weekly\u00a0\ud835\udde0\ud835\uddfc\ud835\uddfb\ud835\uddf1\ud835\uddee\ud835\ude06 \ud835\udde0\ud835\uddfc\ud835\uddff\ud835\uddfd\ud835\uddf5\ud835\uddee\ud835\uddf6\ud835\ude00 \ud835\udde3\ud835\uddfc\ud835\ude00\ud835\ude01.\u00a0\ud83d\ude0e\n\nThis week, we have uploaded\u00a0\ud835\udfee\ud835\udfed\ud835\udfef \ud835\uddfb\ud835\uddf2\ud835\ude04 \ud835\uddf1\ud835\uddf2\ud835\uddee\ud835\uddf9\ud835\ude00\u00a0(including\u00a0\ud835\udff0\ud835\udfef \ud835\ude00\ud835\ude01\ud835\uddf2\ud835\uddee\ud835\uddf9\ud835\ude01\ud835\uddf5 \ud835\uddf3\ud835\uddfc\ud835\ude02\ud835\uddfb\ud835\uddf1\ud835\uddf2\ud835\uddff\ud835\ude00) from\u00a0\ud835\udfed\ud835\udff4 \ud835\uddf0\ud835\uddfc\ud835\ude02\ud835\uddfb\ud835\ude01\ud835\uddff\ud835\uddf6\ud835\uddf2\ud835\ude00\u00a0to our platform,\u00a0with a focus on some really\u00a0\ud835\ude00\ud835\uddfa\ud835\uddee\ud835\uddff\ud835\ude01 \ud835\udde3\ud835\uddf5\ud835\uddd7 \ud835\uddf3\ud835\uddfc\ud835\ude02\ud835\uddfb\ud835\uddf1\ud835\uddf2\ud835\uddff\ud835\ude00\u00a0from\u00a0the BioTech and MedTech space. \ud83d\udc68\ud83c\udffb\ud83d\udd2c\ud83e\uddec\n\nSee our\u00a0\ud835\udde7\ud835\uddfc\ud835\uddfd \ud835\udfef \ud835\uddd7\ud835\uddf2\ud835\uddee\ud835\uddf9\ud835\ude00\u00a0of the week down below! \u2b07\ufe0f\n\n---\n\n(1) \ud83c\udde9\ud83c\uddea aiomics (Dr. Sven Jungmann, Nikita Tarasov & Karim Galzahr)\n(2) \ud83c\uddec\ud83c\udde7 Aethox Therapeutics (Charles Spicer, James Arnold & Khondaker Miraz Rahman)\n(3) \ud83c\udde9\ud83c\uddea Stealth Founder: Christoph Sch\u00fctte\n\nGet \ud835\udfee\ud835\udfec\ud835\udfec+ \ud835\uddf1\ud835\uddf2\ud835\uddee\ud835\uddf9\ud835\ude00\u00a0on a weekly basis - get started with our newsletter and our Free Demo today. Links are in the comments! \u2b07\ufe0f",
        "reactions_count": 13,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      },
      {
        "followers": 3476,
        "date": "1w",
        "description": "\ud83d\udea8 \ud835\udde0\ud835\uddfc\ud835\uddff\ud835\uddfd\ud835\uddf5\ud835\udde5\ud835\uddee\ud835\uddf1\ud835\uddee\ud835\uddff \u2013 \ud835\udde7\ud835\uddfc\ud835\uddfd \ud835\udfef \ud835\udde6\ud835\ude01\ud835\uddee\ud835\uddff\ud835\ude01\ud835\ude02\ud835\uddfd\ud835\ude00 \ud835\uddfc\ud835\uddf3 \ud835\ude01\ud835\uddf5\ud835\uddf2 \ud835\uddea\ud835\uddf2\ud835\uddf2\ud835\uddf8 \ud83d\udea8 \n\nWe hope your portfolio is doing fine. \ud83d\udc40\n\nSeriously:\u00a0While the market currently feels like an on/off situationship,\u00a0there is at least one constant you can count on in your life \u2013\u00a0the weekly\u00a0\ud835\udde0\ud835\uddfc\ud835\uddfb\ud835\uddf1\ud835\uddee\ud835\ude06 \ud835\udde0\ud835\uddfc\ud835\uddff\ud835\uddfd\ud835\uddf5\ud835\uddee\ud835\uddf6\ud835\ude00 \ud835\udde3\ud835\uddfc\ud835\ude00\ud835\ude01.\u00a0\ud83d\ude0e\n\nThis week, we have uploaded\u00a0\ud835\udfee\ud835\udfed\ud835\udfef \ud835\uddfb\ud835\uddf2\ud835\ude04 \ud835\uddf1\ud835\uddf2\ud835\uddee\ud835\uddf9\ud835\ude00\u00a0(including\u00a0\ud835\udff0\ud835\udfef \ud835\ude00\ud835\ude01\ud835\uddf2\ud835\uddee\ud835\uddf9\ud835\ude01\ud835\uddf5 \ud835\uddf3\ud835\uddfc\ud835\ude02\ud835\uddfb\ud835\uddf1\ud835\uddf2\ud835\uddff\ud835\ude00) from\u00a0\ud835\udfed\ud835\udff4 \ud835\uddf0\ud835\uddfc\ud835\ude02\ud835\uddfb\ud835\ude01\ud835\uddff\ud835\uddf6\ud835\uddf2\ud835\ude00\u00a0to our platform,\u00a0with a focus on some really\u00a0\ud835\ude00\ud835\uddfa\ud835\uddee\ud835\uddff\ud835\ude01 \ud835\udde3\ud835\uddf5\ud835\uddd7 \ud835\uddf3\ud835\uddfc\ud835\ude02\ud835\uddfb\ud835\uddf1\ud835\uddf2\ud835\uddff\ud835\ude00\u00a0from\u00a0the BioTech and MedTech space. \ud83d\udc68\ud83c\udffb\ud83d\udd2c\ud83e\uddec\n\nSee our\u00a0\ud835\udde7\ud835\uddfc\ud835\uddfd \ud835\udfef \ud835\uddd7\ud835\uddf2\ud835\uddee\ud835\uddf9\ud835\ude00\u00a0of the week down below! \u2b07\ufe0f\n\n---\n\n(1) \ud83c\udde9\ud83c\uddea aiomics (Dr. Sven Jungmann, Nikita Tarasov & Karim Galzahr)\n(2) \ud83c\uddec\ud83c\udde7 Aethox Therapeutics (Charles Spicer, James Arnold & Khondaker Miraz Rahman)\n(3) \ud83c\udde9\ud83c\uddea Stealth Founder: Christoph Sch\u00fctte\n\nGet \ud835\udfee\ud835\udfec\ud835\udfec+ \ud835\uddf1\ud835\uddf2\ud835\uddee\ud835\uddf9\ud835\ude00\u00a0on a weekly basis - get started with our newsletter and our Free Demo today. Links are in the comments! \u2b07\ufe0f",
        "reactions_count": 12,
        "comments_count": 1,
        "reshared_post_author": null,
        "reshared_post_author_url": null,
        "reshared_post_author_headline": null,
        "reshared_post_description": null,
        "reshared_post_date": null,
        "reshared_post_followers": null
      }
    ],
    "funding_rounds": [
      {
        "last_round_investors_count": 1,
        "total_rounds_count": 2,
        "last_round_type": "Pre seed",
        "last_round_date": "2025-09-18",
        "last_round_money_raised": 2300000,
        "cb_url": "https://www.crunchbase.com/funding_round/aiomics-pre-seed--148d8c7c"
      }
    ],
    "technologies": [
      {
        "technology": "linkedin",
        "first_verified_at": "2025-08-05",
        "last_verified_at": "2025-10-20"
      },
      {
        "technology": "impact",
        "first_verified_at": "2025-08-05",
        "last_verified_at": "2025-08-11"
      }
    ],
    "phone_numbers": [],
    "emails": [],
    "pricing_available": false,
    "free_trial_available": false,
    "demo_available": false,
    "is_downloadable": false,
    "mobile_apps_exist": false,
    "online_reviews_exist": false,
    "api_docs_exist": false
  },
  "status_code": 200
}